Michael Barera / CC BY-SA 4.0 https://creativecommons.org/licenses/by-sa/4.0/ . Dallas skyline viewed from Santa Fe Trestle Trail, September 5, 2016. Archive geographic illustration only, NOT Topgolf premises, bay, prices or November 2026 event. Native landscape no crop/alteration.

URL has been copied successfully!

Michael Barera / CC BY-SA 4.0

Topgolf announced in Dallas, Texas, on November 9 that it was lowering standard gameplay prices across all of its more than 100 U.S. venues, effective immediately, by an average of more than 20%. The company describes the change as a new pricing structure rather than a limited-time promotion, but the reduction is a system-wide average, not a promise that every customer will pay 20% less for every booking.

The company’s announcement, issued at 9:15 a.m. Eastern, says no promotional code is required. Its claim concerns hourly gameplay bay prices. Food and drinks remain outside the comparison, and the price for a visit depends on the venue, day and time. The release does not provide a nationwide dollar rate or a venue-by-venue schedule of reductions.

Topgolf’s pricing terms explain that the comparison uses the simple average of standard hourly list prices across U.S. venues open at the time, covering hours from 9 a.m. to midnight, Monday through Sunday, against the same average in its historical records. Past promotions, discounts and package prices are excluded. A particular venue’s price at a particular hour may therefore not be lower than every price previously offered there.

The checkout total can also be higher than the advertised gameplay rate. The terms exclude taxes, fees and service charges from listed prices and say a $6 account activation fee applies to first-time players. Walk-in prices may exceed reservation prices at some venues. Higher prices may apply on selected dates, including Thanksgiving Day, Christmas Day, New Year’s Eve and Father’s Day.

For families or groups weighing an outing, the useful change is a lower standard pricing average without having to find a coupon. It is not a reduction in every part of the bill. The stated price claim does not cover food and beverages, event packages, memberships including Practice Pass, arcade games, Topgolf Live, Topgolf Lounge, Toptracer ranges, Topgolf Swing Suite or non-U.S. venues.

The company says high cost was the leading reason guests gave for not returning more often, following six months of surveys, social-media analysis and in-person interviews. It reported that 78% of survey respondents cited social connection and 72% cited food, drinks and service as reasons for visiting. The announcement does not disclose the exact survey sample size, questionnaire or weighting, so those percentages are company-reported feedback rather than an independently measured national consumer trend.

For Topgolf, lower prices are an attempt to make repeat visits more attractive. Whether more play offsets the lower amount charged per hour will depend on attendance, spending and operating costs that the announcement does not quantify. The company also says new arcade games are due across all U.S. venues by year-end and points to menu changes and its previously announced TMRW Sports partnership. Those additions should not be confused with a cut to arcade, food or event prices.

The company has not disclosed the expected effect on revenue, margins or visit frequency, and its pricing terms allow rates to change without notice. Customers in New Jersey, New York or elsewhere should compare the exact venue, date, time and final booking total before assuming a particular saving. The confirmed national change is the lower average standard gameplay price effective November 9, not a uniform all-in price for every outing.

JBizNews Desk | Dallas, Texas

© JBizNews.com. All rights reserved. Unauthorized reproduction or redistribution is strictly prohibited.

Share this story:
Share by Email
X (Twitter)
Follow Me
Tweet
Whatsapp
LinkedIn
Copy link
Lluck002 / CC BY-SA 4.0 https://creativecommons.org/licenses/by-sa/4.0/ . Tysons Corner, Virginia skyline panorama May 18, 2017. Geographic archive illustration only, NOT identified Strategy premises, bitcoin assets, people or November 2026 transaction. Native 2.5:1 landscape, no crop or alteration.

URL has been copied successfully!

Lluck002 / CC BY-SA 4.0

Strategy, based in Tysons Corner, Virginia, reported on November 9 that it had acquired 1,036 bitcoin at an average price of $79,012 per coin, for a rounded acquisition cost of $82 million. The company’s latest bitcoin ledger lists total holdings of 850,364 BTC at an average acquisition price of $75,456.

The figures appear in entry 126 of Strategy’s bitcoin ledger, dated November 9, 2026. The acquisition cost is displayed in millions of dollars, so the $82 million figure is rounded rather than an exact transaction total. The reported average purchase price describes this acquisition, not bitcoin’s live market price or a forecast of where it will trade.

The ledger’s totals row lists aggregate acquisition cost of $64.165 billion for the bitcoin represented in the current balance. Strategy explicitly says that bitcoin sold, along with the corresponding average acquisition price and acquisition cost, is removed from that totals row. The figure therefore should not be described as every dollar the company has ever spent buying bitcoin.

This report uses the company’s stated 850,364 BTC total rather than calculating a new balance from the preceding entry. The November 2 row and the November 9 acquisition quantity do not reconcile exactly with the latest stated total. The ledger does not explain the difference, so a reconstructed week-to-week change would introduce precision the source does not support.

The purchase matters to investors because it adds to Strategy’s exposure to bitcoin. A larger bitcoin balance makes movements in the cryptocurrency’s price important to the value of that holding, but the number of coins alone does not establish a return for shareholders. The $75,456 average acquisition price is a historical cost measure, not a guaranteed floor for bitcoin or Strategy’s shares.

The ledger also contains earlier negative acquisition entries and a note explaining how sales are treated in the totals. It would be inaccurate to describe Strategy as a company that never sells bitcoin. The latest positive acquisition entry establishes a new reported purchase; it does not announce an irrevocable promise about future buying or selling.

Monday’s ledger provides the quantity acquired, the average price, a rounded cost and the latest reported balance. It does not by itself identify the specific trading counterparties, exact execution times or the financing source for this purchase. No assertion about new share issuance, preferred-stock repurchases or a stock-market reaction is made here on the basis of that table.

The next questions are how Strategy funds further purchases, how its obligations and capital structure develop, and whether it corrects or explains the reconciliation difference between ledger entries. Future purchases or sales remain decisions to be reported, not outcomes guaranteed by Monday’s update. For now, the confirmed development is the company’s newly reported 1,036-BTC acquisition and its stated total holdings.

JBizNews Desk | Tysons Corner, Virginia

© JBizNews.com. All rights reserved. Unauthorized reproduction or redistribution is strictly prohibited.

Share this story:
Share by Email
X (Twitter)
Follow Me
Tweet
Whatsapp
LinkedIn
Copy link
Ynhockey / CC BY-SA 4.0 https://creativecommons.org/licenses/by-sa/4.0/ . Tel Aviv and Ramat Gan skylines from Tel Aviv University, July 29, 2022. Archive geographic illustration only, NOT Spines premises, employees, product or November 2026 funding event. Full native landscape, no crop or alteration.

URL has been copied successfully!

Ynhockey / CC BY-SA 4.0

Spines announced in Tel Aviv, Israel, and New York on November 9 that it had secured $64 million in growth capital for its AI-assisted publishing platform, split between a $29 million equity round and a $35 million financing facility. The distinction matters: the announcement is not a $64 million equity investment, and a financing facility does not establish that the entire amount has already been drawn.

Zeev Ventures led the Series A-1 equity round, with Aleph, NordStar, M-Fund, LionTree and angel investor Dan Senor participating, according to the company’s release issued at 8:30 a.m. Eastern. Twelve provided the separate facility, which Spines describes as non-dilutive growth financing. The company disclosed neither a valuation nor the facility’s pricing, repayment terms, security, conditions for drawing funds or amount already used.

Spines said it had reached a $50 million revenue run rate and reported 400% year-over-year growth. Although the release’s subheading calls the figure revenue, the body describes a run rate, not revenue booked over a completed reporting period. The announcement does not explain how that rate was calculated, identify the exact comparison period behind the growth percentage or provide audited financial statements.

The company says more than 8,000 American authors have published through the platform and roughly 400 new authors join each month. Those are company-reported measures of activity, not evidence that every author earns a profit. Spines did not disclose revenue per author, customer retention, the number of titles sold, author earnings or its own profitability.

Authors bring their own manuscripts to Spines. The company says its specialized AI agents handle tasks including editing, proofreading, cover design, formatting, metadata, translation, audiobook production, distribution, marketing and royalty management. It also offers access to in-house human editors, proofreaders, designers and native-speaking language professionals. The business is built around the work that comes after writing, rather than a claim that software should replace the author.

“We don’t believe the future of publishing is AI writing books. We believe the future is AI giving authors superpowers,” said Yehuda Niv, Spines’ founder and CEO. He said the writing, story and knowledge come from the author, while the company’s role is to provide the technology and infrastructure for publishing and reaching an audience.

Spines says it distributes books through more than 100 channels worldwide, tracks sales and centralizes royalty management. Its campaign tools are designed to help authors find readers. That reach may make it easier to put a book on sale across markets, but distribution access and marketing tools do not guarantee demand, sales or an author’s financial return. The release provides no independent comparison of publishing speed, quality or author outcomes.

Translation from English is currently available into Spanish, Italian, French, German, Portuguese, Polish and Hebrew, using AI translation with native-speaking human review, according to Spines. The company plans to reach 20 target languages within six months; that is an expansion goal, not an existing capability. It also describes synthetic-voice audiobooks, models of an author’s own voice made from a short recording, and illustration tools designed to keep children’s-book characters consistent across a title. Those are the company’s product descriptions, not independently tested performance findings.

For authors, the practical question is whether one platform can reduce the time and coordination involved in turning a manuscript into a book without sacrificing quality or leaving costs unclear. For investors, the new capital backs that publishing workflow and the push into more languages. The announcement leaves important details open: equity valuation and ownership, financing obligations, service pricing, the scale of human review, and whether the reported growth translates into lasting profits for Spines or better earnings for its authors.

JBizNews Desk | Tel Aviv, Israel / New York

© JBizNews.com. All rights reserved. Unauthorized reproduction or redistribution is strictly prohibited.

Share this story:
Share by Email
X (Twitter)
Follow Me
Tweet
Whatsapp
LinkedIn
Copy link
Archive New Brunswick, New Jersey skyline photograph by William A. Paxton, 2012. CC BY 3.0 https://creativecommons.org/licenses/by/3.0/ . Native landscape, no crop or alteration. Not Vaneltix or Hyloris premises, Alenura, trial participants or the November 2026 announcement.

URL has been copied successfully!

Photo by William A. Paxton, 2012 / CC BY 3.0

Vaneltix Pharma of New Brunswick, New Jersey, and Hyloris Pharmaceuticals of Liège, Belgium, said November 9 that their experimental bladder-pain treatment Alenura met the main goal of a Phase 2 U.S. trial. The companies reported better pain relief than placebo and either ingredient given alone, but did not disclose the size of the benefit or adverse-event results. Alenura remains in clinical development, not an FDA-approved treatment.

The companies’ release, issued at 7 a.m. Eastern, describes a randomized, double-blind, four-arm study of 153 adults with interstitial cystitis/bladder pain syndrome, or IC/BPS, during acute episodes of moderate-to-severe bladder pain. Participants received a single treatment placed directly into the bladder: Alenura, placebo, alkalinized lidocaine or heparin alone. The design tests whether combining the ingredients adds benefit beyond either one by itself.

The main measure was SPID-12, the sum of changes in bladder-pain intensity over the 12 hours after treatment. The trial registry describes pain ratings on a zero-to-10 scale, where zero is no pain and 10 is the worst imaginable pain. The companies said Alenura was statistically superior to all three comparators, with every reported p-value below 0.01.

That statistical result is not a numerical description of how much better patients felt. The announcement provides neither the treatment differences nor confidence intervals, and gives no actual participant count for each arm. Without those figures, readers cannot assess the size and precision of the reported advantage or how consistently patients experienced it.

Pain-relief assessments at 24 hours also favored Alenura, the companies said, alongside supportive patient-reported symptom improvements. They did not provide numerical 24-hour results. A single-dose study measured over hours should not be read as proof of lasting control of a chronic condition, prevention of future flares or a cure.

Alenura combines alkalinized lidocaine, a local anesthetic, with heparin in a ready-to-use bladder instillation. The companies describe lidocaine as intended to provide rapid relief and heparin as intended to support the bladder’s protective lining and potentially sustain relief. Those descriptions explain the development rationale; they do not establish the mechanism or clinical benefit independently of the trial data.

IC/BPS can involve recurring bladder and pelvic pain or discomfort, often alongside urinary urgency and frequency. For patients, the importance of this announcement is the possibility of another treatment for painful flares, rather than an available new prescription today. For the developers, superiority to both individual components supports their case for continuing work on the combination, while leaving the remaining evidence and regulatory review ahead.

The public registry still lists estimated enrollment of 120 and a recruiting status, while the new release reports 153 adults evaluated. Its planned arm counts are anticipated figures, not confirmed final results. The registry supports the study design but has not been reconciled with the company’s latest participant total in the record reviewed for this report. The release does not identify a peer-reviewed paper or provide the adverse-event findings needed to assess tolerability.

Vaneltix and Hyloris said additional development work is continuing to support preparations for a U.S. New Drug Application under the 505(b)(2) pathway, subject to the remaining clinical and regulatory requirements. They announced no submission date. Preparing an application is different from filing it, and filing would not itself mean FDA approval. The next useful disclosures are the full efficacy results, safety findings, final arm sizes and a clearer regulatory timetable.

JBizNews Desk | New Brunswick, New Jersey / Liège, Belgium

© JBizNews.com. All rights reserved. Unauthorized reproduction or redistribution is strictly prohibited.

Share this story:
Share by Email
X (Twitter)
Follow Me
Tweet
Whatsapp
LinkedIn
Copy link

URL has been copied successfully!

Good morning!

HR leaders have a new fear: Job candidates asking ChatGPT what their company is really like.

Some 70% of job seekers now use generative AI tools like Claude, ChatGPT, and Perplexity to research employers, new Indeed data shows. And when job seekers ask about company culture, roughly 40% of the sources cited come from Glassdoor and Indeed, not company career pages.

That creates a new challenge for HR. AI is helping shape candidates’ perceptions of employers using information companies don’t directly control. A polished career page may tell one story, while employee reviews tell another—and job seekers can ask a chatbot to piece it all together.

But AI isn’t uncovering anything that isn’t already online, says Taylor Meadows, principal advisor at Glassdoor. His advice is to feed the beast.

“Your employer brand exists whether you are participating in it or not,” Meadows says. He recommends starting with an AI audit, asking different LLMs, “What is it like to work at X company?” Then, “reverse engineer” the problems that surface.

Meadows also suggests publishing Q&As addressing real questions from employees and candidates on social media and third-party review sites. “Let that be the good, the bad, and the ugly,” he says. “It’s going to be an opportunity for you to talk about what’s going well, but then it’s going to also be an opportunity to exercise some humility.”

Companies should also create content that showcases what it’s like to work in different departments, since culture can vary by team. Encouraging employees to share authentic experiences helps, too, Meadows says.

Even offboarding matters. Departing employees may leave reviews that AI later surfaces, making their final impression of the company especially important.

“None of this is about perfection and none of this is about control,” Meadows says. “It’s just about informing and influencing.”

Kristin Stoller
Editorial Director, Fortune Live Media
kristin.stoller@fortune.com

This story was originally featured on Fortune.com

Share this story:
Share by Email
X (Twitter)
Follow Me
Tweet
Whatsapp
LinkedIn
Copy link

This post was originally published here. 

URL has been copied successfully!

She’s back. Sen. Elizabeth Warren (D-Mass.), the longtime scourge of the crypto industry, is poised to return as a political force in January. That’s when Warren is expected to take over as Chair of the powerful Senate Banking Committee—a role that is critical for steering financial legislation, and comes with broad subpoena and investigative power. This is not exactly good news for crypto firms, of course. The question, though, is whether—just maybe—Warren and the industry can lay aside old antagonisms in order to advance both consumer protection and financial innovation.

As background, the bad blood between Warren and the crypto industry stems from the Biden years. That’s when former Securities and Exchange Commission Chair Gary Gensler set out to basically extinguish the U.S. crypto industry with a spate of lawsuits and investigations. Among Washington D.C. insiders, many saw Warren and her staffers as the architects of Gensler’s campaign.

In response to that Biden-era legal onslaught, the crypto industry overcame its longtime disdain of Washington politics, and it waged a big-money campaign in 2024 to elect President Trump, and to drive critics from Congress. The campaign worked stunningly well. Crypto firms helped sweep Trump into office, leading to a hands-off regulatory environment that left Warren fuming ineffectively on the sidelines.

Now, the shoe is on the other foot again. Despite blowing around $170 million on campaign ads to boost Republican candidates in the midterms, the crypto industry had what one lobbyist described simply as an “awful night.” Not only did crypto firms fail to do anything to stop the Democrats’ blue wave, they made tactical choices that look downright foolish in hindsight. That includes spending over $63 million in a failed bid to defeat crypto skeptic Sherrod Brown (D-Ohio), who not only won his Senate race by a comfortable margin, but will likely become Chair of the Agriculture Committee, which oversees commodities regulation.

When they are wielding committee gavels next January (which is widely expected but not confirmed), don’t expect Warren and Brown to do the crypto industry any favors. But it doesn’t necessarily follow that we’ll see a return to the scorched earth tactics of the Biden years. Ron Hammond, Head of Policy at Wintermute, notes that a recent Time essay by Warren appeared to telegraph her agenda. The essay puts CEOs of various industries on notice and promises to target Trump family corruption, but makes no mention at all of crypto—potentially a sign the industry will not be an immediate target.

Hammond, who is deeply plugged into the D.C. crypto scene, also noted that the crypto firms that stand to lose the most from Warren’s return are those that are seeking out or have obtained banking charters. In this scenario, Warren may ally with traditional banks, which earlier this year helped smother the Clarity Act, in order to block or roll back those charters.

Warren and her allies will be unable to make any drastic moves, though, because the Trump-appointed heads of key financial agencies—including the SEC, CFTC, and OCC—will hold their positions until the end of his term. This means that, for the next year or two, we can expect moves by Warren that are symbolic in nature, but that point to where she and the Democratic Party are heading in 2028.

Politics is never static, and while it’s a safe bet that Warren is not going to become a Bitcoin HODLer, there is a world where the Senator becomes less antagonistic. As an olive branch, she could acknowledge the undeniable benefits of blockchain innovations like stablecoins, as well as the popularity of crypto among younger Americans.

As for the crypto industry, the midterm results delivered a long overdue lesson that politics in Washington D.C. is a long game and that, while trying to bludgeon critics with PAC money may feel satisfying, it’s not the most effective strategy. And while crypto CEOs will never see eye-to-eye with Liz Warren—their respective libertarian and progressive worldviews are simply too different—there is room to acknowledge her advocacy for consumers is sincere, even if it is at times misguided.

Maybe all of this is naive, but last week’s election results felt like a break from politics as usual. Voters appear exhausted by jerks on both the left and the right and, for now at least, moderation is the order of the day. How refreshing would it be if Liz Warren and the crypto industry came to recognize that too?

Jeff John Roberts
jeff.roberts@fortune.com
@jeffjohnroberts

This story was originally featured on Fortune.com

Share this story:
Share by Email
X (Twitter)
Follow Me
Tweet
Whatsapp
LinkedIn
Copy link

This post was originally published here. 

Stig Nygaard / CC BY 3.0. Nyhavn, Copenhagen, Denmark, April 5, 2012. Archive location illustration, NOT Nordea premises, the court building, alleged transactions or the current verdict event. Native 3:2 landscape full supplied image resized without crop.

URL has been copied successfully!

Stig Nygaard / CC BY 3.0

Nordea said Copenhagen City Court in Copenhagen, Denmark, fined the bank DKK 155 million on November 9 over two counts concerning the adequacy of its anti-money-laundering processes and controls in 2012 through 2015. The bank said it was acquitted on five of seven counts and would review the judgment before deciding whether to appeal.

The bank’s statement valued the fine at approximately EUR 20 million and contrasted it with the DKK 6.6 billion, or approximately EUR 880 million, sought by the prosecution. The lower penalty does not mean the bank was cleared on every count. Nor does a controls case establish that the bank itself committed money laundering.

Nordea emphasized that it had not been charged with money laundering or assisting money laundering. It also said no current or former employees had been suspected or charged in connection with this case. The distinction is between whether required safeguards were adequate and a charge that the bank or an employee carried out the underlying crime.

The conduct at issue dates to 2012-15, rather than the bank’s current operations. Monday’s development is the court’s verdict in that historic case. Nordea’s release does not describe the detailed reasoning behind the two counts that resulted in a fine, and the bank said its review would cover both the conclusions and the court’s reasoning.

For investors, the immediate question is the financial effect and whether the dispute continues. Nordea said it was adequately provisioned and that the verdict had no immediate financial impact. Those are the bank’s statements about its accounting position; they do not mean the penalty has been canceled or that no compliance spending will be needed in the future.

The initial appeal period is two weeks from the verdict, according to Nordea. If prosecutors appeal all or part of the judgment, the bank would have an additional two weeks to decide on a counterappeal. Any appeal would go to Denmark’s Eastern High Court, with a later Supreme Court appeal potentially possible under the applicable rules. The release does not announce an appeal by either side.

Nordea said it continues to invest in fighting money laundering and other financial crime and works with authorities. That statement describes the bank’s position, not an independent assessment that every current safeguard is adequate. The court outcome matters because controls are intended to detect and prevent misuse of banking services, even when a bank is not accused of laundering money itself.

The open questions are the full reasoning for the upheld counts, whether either side appeals and whether the judgment leads to any further action. The bank has not yet announced its appeal decision. Until those matters are settled, the verdict should be described as a fine on two counts alongside five acquittals, not a complete exoneration or a finding that the bank was charged with money laundering.

JBizNews Desk | Copenhagen, Denmark

© JBizNews.com. All rights reserved. Unauthorized reproduction or redistribution is strictly prohibited.

Share this story:
Share by Email
X (Twitter)
Follow Me
Tweet
Whatsapp
LinkedIn
Copy link
Ben+Sam / CC BY-SA 2.0 https://creativecommons.org/licenses/by-sa/2.0/ . New York Stock Exchange exterior, July 12, 2008 archive. NOT the upcoming affiliated platform, Avalanche infrastructure, launch or November 2026 event. Native4:3 landscape, no crop/alteration. Source: https://commons.wikimedia.org/wiki/File:New_York_Stock_Exchange_(2666765776).jpg

URL has been copied successfully!

Ben+Sam / CC BY-SA 2.0

Ava Labs announced in New York on November 9 that Avalanche will provide the core ledger technology to the clearing firm supporting an upcoming NYSE-affiliated digital trading platform for tokenized securities. The planned platform is designed for around-the-clock trading, clearing and settlement, but remains subject to applicable regulatory approvals and is not being announced as live.

The company’s release describes infrastructure for a new affiliated alternative trading system, not a move of all New York Stock Exchange trading onto Avalanche. Its role is the ledger that records and settles trades through the platform’s clearing infrastructure. The announcement does not say every stock offered on the new platform must be issued on Avalanche.

“At the NYSE, we’re looking at how blockchain technology can expand what we offer in equities, and we’re picking the right technology for each job,” said Dennis Lee, Head of Digital Issuance, NYSE. “The upcoming digital trading platform will support equities listed on a range of blockchains, though the ledger that records and settles trades needs to be fast and reliable, let us control who can take part, keep costs predictable, and have a large community of developers behind it. Avalanche meets all those needs.”

That distinction separates the blockchain on which a security is represented from the infrastructure used to record and complete a trade. Tokenization gives an asset a digital representation on a blockchain; clearing and settlement concern the arrangements that complete the exchange. Monday’s announcement places Avalanche in that underlying infrastructure for the planned affiliated platform, rather than announcing that the existing exchange or every listed company’s shares are changing systems.

Ava Labs Chief Executive Emin Gün Sirer said the technology would support the platform’s 24/7 atomic settlement needs, with dedicated infrastructure and control over participation, performance and costs. Atomic settlement is intended to complete the linked parts of an exchange together. The promised speed, reliability and cost predictability are statements by the companies about the planned design, not independently measured operating results from a live platform.

The business significance is the proposed use of blockchain within market infrastructure, beyond issuing a single tokenized fund or share. If the platform receives approvals and opens, its subscribers could use a market designed to operate beyond traditional trading hours. But a 24/7 design is not evidence that access, liquidity or uninterrupted operation is already available, and the release does not set out final eligibility or operating rules.

Avalanche’s separate company explanation says the clearing infrastructure is intended to give the market operator greater control over capacity, economics and network participation. Those are the project’s stated aims. The materials do not identify the clearing firm by name or disclose commercial contract terms, fees, transaction value or a launch date.

The remaining questions include the approval timetable, which customers will be able to participate, which securities will be available at opening, and how the system will perform in actual trading and settlement. Neither announcement reports final regulatory approval or an operating transaction volume. The development is a technology selection for an upcoming platform, not proof that a new market has opened or a claim about the price of Avalanche’s AVAX token.

JBizNews Desk | New York

© JBizNews.com. All rights reserved. Unauthorized reproduction or redistribution is strictly prohibited.

Share this story:
Share by Email
X (Twitter)
Follow Me
Tweet
Whatsapp
LinkedIn
Copy link
CommunistSquared / CC0. Midtown Manhattan skyline, June 27, 2019. Archive New York location illustration, NOT Fanatics or American Express offices, actual credit-card designs, athletes or launch event. Full native 3:2 landscape resized without crop.

URL has been copied successfully!

CommunistSquared / CC0

Fanatics and American Express, whose headquarters is in New York, New York, unveiled a sports-themed credit card on November 9, opening a U.S. waitlist rather than immediate applications. The Fanatics American Express Card is issued by First Electronic Bank through Imprint on the American Express Network. It earns FanCash, Fanatics’ loyalty currency, not ordinary cash back.

The companies’ announcement says invitations to apply will begin later this year. Joining the waitlist is not a credit approval or an open account. A Fanatics ONE account is required to hold the card, and customers will be able to choose from more than 500 trading-card-inspired designs featuring NBA, NFL, UFC and WWE athletes.

The advertised rewards include 5% FanCash on eligible purchases across Fanatics merchants, including Fanatics.com, Lids, Mitchell & Ness, Fanatics Collect, Fanatics Live and Topps.com. Purchases through the Fanatics app may earn an additional 3% or more, bringing the advertised total to 8% or more. The release also advertises 5% on tickets and select streaming services, but its footnote limits 5% rewards at select Fandom merchants to $5,000 of annual spending. Other eligible purchases earn 2%.

Those percentages describe loyalty rewards, not a discount on every purchase or money automatically returned to a bank account. FanCash can be redeemed across the Fanatics platform for items and experiences including apparel, collectibles, trading cards and tickets. The practical value depends on what a customer can redeem and wants to buy, as well as which transactions qualify under the rewards terms.

Fanatics advertises no annual fee, but the release does not give numerical annual percentage rates or a complete schedule of credit fees and terms. No annual fee does not mean borrowing is interest-free or that no other fees apply. Until applicants can review the cardholder agreement, the cost of carrying a balance cannot be weighed against the advertised rewards from this announcement alone.

The announced offers include $100 in FanCash after $1,000 of qualifying spending within 90 days of opening, plus another advertised $100 in FanCash for spending $500 a month for 12 consecutive months. Terms and eligibility conditions apply. Cardmembers would also receive selected event and presale benefits, with Topps presales and other ticket access subject to availability rather than guaranteed access to a particular product or event.

A planned Championship Challenge would give eligible cardmembers a chance to receive up to $100,000 of annual card spending back by correctly predicting all four MLB, NBA, NFL and NHL champions. The release says timing, structure and eligibility remain subject to change, with full details to be announced before entry. It is a conditional promotion, not a promise that a cardholder’s bill will be paid.

A separate change begins November 9 for eligible U.S. Membership Rewards members with American Express-issued cards: they can transfer 1,000 points for $10 in FanCash. That program is distinct from applying for the new First Electronic Bank-issued card. The transfer creates Fanatics loyalty currency, not a $10 cash withdrawal, and the release does not establish that it is the best redemption choice for any particular member.

For Fanatics, the business aim is to connect merchandise, collectibles, tickets and other sports spending more closely through its loyalty platform. For consumers, the questions are which purchases qualify, when application invitations arrive, and what the final borrowing costs and promotion rules will be. The launch announcement establishes a waitlist and a rewards proposition, not a fully priced credit offer that every fan can already obtain.

JBizNews Desk | New York, New York

© JBizNews.com. All rights reserved. Unauthorized reproduction or redistribution is strictly prohibited.

Share this story:
Share by Email
X (Twitter)
Follow Me
Tweet
Whatsapp
LinkedIn
Copy link
Archive July2023 Nvidia headquarters in SantaClara, California

URL has been copied successfully!

Coolcaesar / Wikimedia Commons / CC BY-SA 4.0 / July 2023 archive

In Beijing, China, on November 9, Foreign Ministry spokesperson Guo Jiakun gave the ministry’s response in its English transcript: “We responded to that last week. The ‘Chinese spy’ allegation is purely unsubstantiated and directed at smearing China.” This is Beijing’s denial, not an independent finding that resolves the allegation or ends Nvidia’s board inquiry.

In the same briefing, Guo was asked about a possible meeting involving U.S. President Donald Trump, Chinese President Xi Jinping and Russian President Vladimir Putin in Shenzhen the following week. He said: “China maintains communication with the relevant parties on the meeting between the three presidents. As for your specific question, I have no information to offer at the moment.” The response confirms communication, not a summit date, location agreement or agenda. It announces no chip approval or reversal of import restrictions, leaving both the diplomatic arrangements and any trade-policy outcome unconfirmed.

China’s foreign ministry rejected the Chinese-spy allegation surrounding Nvidia Chief Executive Jensen Huang on Monday, adding Beijing’s denial to a story now under review by the chipmaker’s independent directors.

At a November 9 briefing, spokesperson Guo Jiakun called the so-called “Chinese spy” narrative unfounded speculation and a smear, according to the ministry’s published transcript. His response addressed a question about reports involving Huang and a Chinese technology executive. This is China’s denial of the allegation, not an independent finding about what happened.

The denial does not establish the outcome of Nvidia’s inquiry. For the company and its shareholders, the central unanswered issue remains what the directors’ review will find and whether any sensitive information was compromised. Nvidia’s board has said it has no reason to believe that national security or company secrets were compromised, while committing to examine all available information.

Nvidia’s board launched an independent investigation Sunday after reporting that founder and Chief Executive Jensen Huang had been targeted by a foreign intelligence effort.

A committee of independent directors, assisted by outside independent counsel, will oversee the inquiry, the board said in its November 8 statement. Huang supports the review and has committed to cooperating with it.

“While the Board has no reason to believe that either national security or NVIDIA secrets were compromised, the Board’s inquiry will examine all available information,” the statement said.

The directors said U.S. national and economic security is “paramount to the interests of NVIDIA and its shareholders.” Their decision puts oversight of the review with independent directors and outside counsel while the company examines the information available to it.

The board also expressed confidence in Huang and his leadership team. It said it would provide further updates as appropriate.

In overnight trading, Robinhood’s NVDA page showed Nvidia at $178.57 at 12:44:02 a.m. Eastern on November 9, down $8.07, or 4.32%, in the platform’s 24 Hour Market. This was an overnight venue quote, not a regular-session closing price.

JBizNews Desk | New York

© JBizNews.com. All rights reserved. Unauthorized reproduction or redistribution is strictly prohibited.

Share this story:
Share by Email
X (Twitter)
Follow Me
Tweet
Whatsapp
LinkedIn
Copy link

URL has been copied successfully!

Only a “very small percentage” of Vietnam’s exports to the U.S. are illegally transshipped, Marc Knapper, the former U.S. ambassador to Vietnam, said on Nov. 3, as the Trump administration tries to apply the term to a wider set of supply chain activities.

“The term transshipment has come to mean different things to different people,” Knapper, who served as the U.S.’s top diplomat in Vietnam from 2022 to 2026, explained at the Fortune Southeast Asia 500 Summit in Ho Chi Minh City. 

Illegal transshipment is the falsification of a good’s country of origin to evade tariffs. For example, a Vietnamese exporter that imports a finished product from China, labels its country of origin as Vietnam, and then exports it to the U.S., is conducting illegal transshipment. Such activity is “fraudulent,” Knapper said, adding that Vietnam has been “cracking down pretty hard” on it, working with counterpart customs agencies, including U.S. Customs and Border Protection.

However, elements of the Trump administration have offered a more expansive definition of transshipment that includes what Knapper called “broader supply chain activity…the kind of things that every country does, including the United States, which is [to] assemble things based on inputs from neighboring countries.” He added that “some have falsely labeled normal supply chain activities as transshipment.”

The Trump administration claims that this activity—shifting some parts of a Chinese supply chain overseas to take advantage of lower tariffs—hurts the U.S. economy and denies it tariff revenue. In August, the White House Office of Trade and Manufacturing Policy accused over 40 economies of running a “Great Transshipment Scam” with estimated federal revenue losses of $19 billion to $26 billion a year.

Vietnam’s goods trade surplus with the U.S. reached $140 billion in the first ten months of the year. Knapper pointed out this surplus grew “in spite of the tariffs imposed by the United States on Vietnam…American consumers, American manufacturers, love made in Vietnam.”

Under an initial trade agreement announced in July 2025, Vietnam accepted a 20% tariff on its regular exports to the U.S., and a 40% tariff on goods deemed to have been transshipped from China, though the deal didn’t specify how that would be calculated. (That deal is now in limbo following the U.S. Supreme Court’s decision in February deeming most of U.S. President Donald Trump’s tariffs to be unlawful).

Currently, the U.S. levies a 12.5% tariff on many Vietnamese goods, imposed after a Section 301 investigation alleged the country hadn’t done enough to combat forced labor. 

‘Chuhai’

Many companies have shifted parts of their supply chains out of China and into Southeast Asia in recent years in what’s become known as a “China plus one” strategy. Rising U.S. protectionism, increasing costs in China, and a greater push for supply-chain resilience are encouraging this shift.

Chinese companies are also eager to expand into the region, seeing it not just as manufacturing destination but also as a new consumer market. “They call it their chuhai strategy, which means getting out of China and doing business in Southeast Asia and Vietnam,” Yap Kwong Weng, CEO of Vietnam SuperPort, said. “The question is, can companies come into Vietnam now, seize the opportunity, and really gain a competitive advantage from it?

China-ASEAN trade exceeded $1 trillion for the first time in 2025, according to China’s State Council.

In August, Vietnam’s National Assembly approved an additional $3.3 billion for a railway linking the country to China. While the project has faced setbacks because of delays in land clearance, officials target completion by 2030.

This story was originally featured on Fortune.com

Share this story:
Share by Email
X (Twitter)
Follow Me
Tweet
Whatsapp
LinkedIn
Copy link

This post was originally published here. 

URL has been copied successfully!

As of 7:30 a.m. Eastern Time today, oil sold for $97.65 per barrel (using Brent as the benchmark, which we’ll get into momentarily). That’s $2.66 lower than yesterday and approximately a $33.50 rise over the past year.

Oil price per barrel % Change
Price of oil yesterday $100.31 -2.65%
Price of oil 1 month ago $106.94 -8.68%
Price of oil 1 year ago $64.15 +52.22%

Will oil prices go up?

It’s impossible to predict the future of oil prices. Several factors determine the movement of oil, but it ultimately boils down to supply and demand. Again, when threats of economic downturn, war, etc. are high, the oil trajectory can turn rapidly.

How oil prices translate to gas pump prices

When you pay for gas at the pump, you’re paying for more than just the crude oil itself; you’re also springing for links along the chain, such as the refineries and wholesalers—not to mention taxes and local gas station markups.

Still, the crude oil aspect affects the final price most dramatically, as it typically accounts for more than half the price per gallon. When oil prices spike, so do gas prices. And frustratingly, when oil prices drop, gas prices tend to take their time drifting down to the lower price (sometimes referred to as “rockets and feathers”).

The role of the U.S. Strategic Petroleum Reserve

In case of emergency, the U.S. has a store of crude oil known as the Strategic Petroleum Reserve. Its primary purpose is energy security in case of disaster (think sanctions, severe storm damage, even war). But it can also go a long way toward softening crippling price hikes during supply shocks.

It’s not a long-term answer—more of an immediate relief to assist the consumer and keep critical parts of the economy running, like key industries, emergency services, public transportation, etc.

How oil and natural gas prices are linked

Oil and natural gas are both major energy fuels. A big change in oil prices can affect natural gas by extension. For example, if oil prices increase, some industries may swap natural gas for some segments of their operations where possible—which increases demand for natural gas.

Historical performance of oil

When examining oil’s performance, there are generally two major benchmarks:

  • Brent crude oil is the main global oil benchmark.
  • West Texas Intermediate (WTI) is the main benchmark of North America.

Between the two, Brent better represents global oil performance because it prices much of the world’s traded crude. And, it’s often the best way to track historical oil performance. In fact, even the U.S. Energy Information Administration now uses Brent as its primary reference in its Annual Energy Outlook.

Looking at the Brent benchmark across several decades, oil has been anything but steady. It’s seen spikes due to factors such as wars and supply cuts, and it’s also seen crashes from global recessions and an oversupply (called a “glut”). For example:

  • The early 1970s brought the first big oil shock when the Middle East cut exports and imposed an embargo on the U.S. and others during the Yom Kippur War.
  • Prices dropped in the mid-1980s for reasons such as lower demand and more non-OPEC oil producers entering the industry.
  • Prices spiked again in 2008 with increased global demand, but it soon plummeted alongside the global financial crisis.
  • During the 2020 COVID lockdown, oil demand collapsed like never before—bringing prices below $20 per barrel.

All to say, oil’s historical performance has been anything but smooth. Again, it’s hugely affected by wars, recessions, OPEC whims, evolving energy initiatives and policies, and much more.

Energy coverage from Fortune

Looking to stay up-to-date regarding the latest energy developments? Check out our recent coverage:

Frequently asked questions

How is the current price of oil per barrel actually determined?

The current price of oil per barrel depends largely on supply and demand, including news about potential future supply and demand (geopolitics, decisions made by OPEC+, etc.). In the U.S., prices also move based on how friendly an administration is to drilling, as it can affect future supply. For example, 2025 saw the Trump administration move to reopen more than 1.5 million acres in the Coastal Plain of the Arctic National Wildlife Refuge for oil and gas leasing, reversing the Biden administration’s policy of limiting oil drilling in the Arctic.

How often does the price of oil change during the day?

The price of oil updates constantly when the “futures” markets are open. A futures market is effectively an auction where people agree to buy or sell oil in the future. As long as people and companies are trading contracts, the oil price is changing.

How does U.S. shale oil production affect the current price of oil?

In short, shale is rock that contains oil and natural gas. Think of shale as energy yet to be tapped. The more shale the U.S. accesses, the more energy we’ll have—and the more easily oil prices can keep from spiking as much thanks to a greater supply.

How does the current price of oil impact inflation and the broader economy?

When oil is expensive, it tends to make everyday items cost more. This can be related to energy (your heating, gas utilities, etc.), but it’s also due to the logistics involved with making those items accessible to you. Shipping, for example, can affect the price of things at the grocery store, as it’s more expensive to get those products from warehouses and farms onto the shelf.

This story was originally featured on Fortune.com

Share this story:
Share by Email
X (Twitter)
Follow Me
Tweet
Whatsapp
LinkedIn
Copy link

This post was originally published here. 

URL has been copied successfully!

Morgan Chittum here. The point of venture capital? Get in early on the next big thing. But when one firm backs a buzzy startup, others often rush to follow. The more compelling—albeit riskier—story belongs to the contrarian: the investor willing to get there first and stand alone.

That’s the kind of bet Bain Capital Ventures’ Ajay Agarwal made more than two decades ago, backing a robotics startup that Silicon Valley investors had largely turned away. The company was Kiva Systems, which Amazon would later acquire for $775 million. 

When Agarwal met Kiva cofounder Mick Mountz in 2004, the company had no revenue, no finished product, and no customers. At the time, software was a quicker, cheaper route to market. But Mountz’s pitch was simple: Instead of making warehouse workers walk the aisles to retrieve products, have robots bring the shelves to them. “Within five minutes of the meeting with Mick, I thought to myself, ‘This is the best meeting I’ve been in in 18 months,’” Agarwal told me. “I didn’t know anything about robotics or hardware, but he explained the problem in a way that you could explain it to your grandmother.” 

Convincing Bain’s partners to invest, however, would take more work. “Their initial reaction, which I don’t blame them for, was ‘We don’t know anything about robots,’” Agarwal said. 

Through Bain’s network, Agarwal connected Kiva’s team with Don Ralph, who ran North American e-commerce fulfillment for Staples, for additional due diligence. That one-hour meeting turned into three. The next day, Ralph called Agarwal: “I’ve been in this industry for 35 years. That was the single most compelling technology I’ve ever seen. You have to invest.” 

Bain later led Kiva’s first funding round and Staples became its first customer. High-profile companies like Zappos, Gap, and Zara followed suit. Eight years later, Amazon bought it for $775 million. Bain told Fortune its initial investment in Kiva generated a 26.6-fold return.

Now, Agarwal sees an even bigger, wider opportunity. “We’re in the golden age of hardware and physical AI,” he said. That’s the technology that lets robots and other machines perceive and act in the real world.

This time, though, the rest of Silicon Valley has joined in. 

Robotics and physical AI startups raised $27.6 billion in funding across 1,009 deals in 2025, more than double the previous year’s total, according to PitchBook figures. Among them is TerraFirma, a construction robotics company that Bain was the first to back in 2024. In July, the startup announced a $100 million Series A led by Kleiner Perkins, with Bain investing again.

What makes Agarwal think this momentum will last? For starters, the talent. TerraFirma’s founders, Noah Schochet and Noah McGuinness, came from SpaceX. Physical Intelligence, another leading robotics startup, was started by Berkeley roboticist Sergey Levine and ex-Google DeepMind researcher Karol Hausman.

“I think it’s a reaction a little bit to people feeling jaded by 20 years of workflow software,” Agarwal said. “People may be feeling like this is not ambitious enough. I want to do something bigger. I want to do something harder.”

The hardware is also cheaper. Many crucial components now cost a fraction of what they did years ago. Part of that comes down to scale: Smartphone and electric vehicle makers buy up cameras, sensors, and batteries in massive quantities, helping drive down the cost of parts that robots use as well. “That means the ROI that you can deliver is so much more compelling,” he said.

Finally, more advanced AI means machines have a better shot at handling real-world scenarios. “They can deal with situations they haven’t seen before,” Agarwal said. “They can adapt and adjust to the edge cases which inevitably happen in a physical environment.”

Twenty-two years ago, Agarwal had to convince his partners to take robots seriously. That’s no longer the hard part. It’s finding a bet the rest of Silicon Valley hasn’t already crowded into. 

See you tomorrow,

Morgan Chittum
X:
@morgan_chittum
Email: morgan.chittum@fortune.com

Submit a deal for the Term Sheet newsletter here.

Joey Abrams curated the deals section of today’s newsletter.

This story was originally featured on Fortune.com

Share this story:
Share by Email
X (Twitter)
Follow Me
Tweet
Whatsapp
LinkedIn
Copy link

This post was originally published here. 

URL has been copied successfully!

Emma Walmsley is joining an exclusive club. When she takes over HP in January, the former GSK chief will become a two-time CEO of a major multinational, having crossed three industries to get there.

Her trajectory offers a revealing study in how executives build careers that make them attractive to boards across industries.

Walmsley spent 17 years at L’Oréal, holding management positions across four global cities before running its consumer products business in China. She joined GSK in 2010, became CEO of its consumer healthcare division in 2015, and took the top job in 2017, becoming the first woman to lead a major pharmaceutical company.

Over nearly nine years, she navigated activist pressure, the pandemic, and the separation of Haleon, GSK’s consumer healthcare company. She also faced investor criticism over GSK’s drug pipeline and shareholder returns. Since 2019, she has served on Microsoft’s board, gaining exposure to the technology industry and a company central to HP’s PC business.

Her appointment follows the departure of Enrique Lores, who rose from engineering intern to CEO during more than three decades at HP before leaving for PayPal in February. After nine months under interim chief Bruce Broussard, HP has chosen a leader whose career followed a strikingly different trajectory.

Her next assignment presents a different commercial challenge.

HP says it needs to unlock growth as AI transforms personal computing. Analysts see more immediate pressures. Rising memory-chip prices are squeezing manufacturers, PC demand faces uncertainty, and the printing business continues to contract.

Walmsley joins a prominent group of executives recruited for another turn in the corner office. Kraft Heinz appointed former Kellanova chief Steve Cahillane in 2026. Verizon tapped former PayPal CEO Dan Schulman in 2025. Starbucks recruited Chipotle chief Brian Niccol in 2024, while Papa John’s hired former Wendy’s CEO Todd Penegor the same year. Mary Dillon, who previously led U.S. Cellular and Ulta Beauty, became Foot Locker’s CEO in 2022.

Their appointments reflect the appeal of executives with established track records running large organizations, navigating competitive pressures, and leading corporate transformations.

According to Spencer Stuart, 21% of incoming S&P 1500 CEOs in 2024 had previously led a public company, up eight percentage points over three years.

But hiring repeat CEOs comes with a revealing complication. In a study of 855 S&P 500 CEOs, Spencer Stuart found that 70% of those who went on to lead another S&P 500 company delivered stronger market-adjusted shareholder returns in their first CEO role. Researchers warned that experienced CEOs can rely too heavily on familiar strategies.

For Walmsley, whose experience restructuring GSK helped establish her credentials, HP presents a test of how readily those skills transfer to a technology business confronting different competitive pressures.

Ruth Umoh
ruth.umoh@fortune.com

This story was originally featured on Fortune.com

Share this story:
Share by Email
X (Twitter)
Follow Me
Tweet
Whatsapp
LinkedIn
Copy link

This post was originally published here. 

Beyond My Ken / CC BY-SA 4.0. Pavonia/Newport Jersey City, New Jersey waterfront skyline, July 29, 2014. Archive regional housing illustration, NOT identified condos offered for sale or September/November 2026 conditions. Full native wide landscape resized without crop.

URL has been copied successfully!

Beyond My Ken / CC BY-SA 4.0

Redfin reported from Seattle, Washington, on November 9 that U.S. condo sellers outnumbered buyers by an estimated 123% in September, the widest gap in its records dating to 2013. The national imbalance did not apply everywhere: Nassau County, New York, remained a seller’s market, while Newark and New Brunswick, New Jersey, were among markets the brokerage classified as balanced.

The company’s report estimated 197,248 condo sellers and 88,460 buyers nationwide in September. Estimated buyers declined 2.5% from August, while sellers rose 0.9%. A 123% seller surplus means roughly 2.23 sellers for each buyer in Redfin’s estimates; it does not mean prices fell by 123% or that every condo seller is unable to find a buyer.

The gap widened from 95.5% a year earlier and reversed conditions during the pandemic housing boom. Redfin said September 2021 had 25.1% fewer sellers than buyers. Over five years, its estimated number of condo buyers fell 54% while sellers rose 36%. These figures describe September conditions released on November 9, not a live count of people seeking condos today.

The national median condo sale price fell 0.8% from a year earlier to about $339,000 in September, according to Redfin. About 37% of condos sold that month had an asking-price reduction, compared with 16% five years earlier. The typical sold condo spent 63 days on the market before going under contract, up from 35 days. A national median and the experience of homes that sold do not establish what any particular unsold unit is worth.

For buyers, a larger choice of listings can create room to negotiate, but the purchase price is only part of the cost. Redfin identified insurance premiums, homeowners association fees and special assessments as pressures on condo ownership, particularly in Florida and Texas. A lower offer price does not remove ongoing building charges or the risk of a future assessment for major repairs.

Local differences are large. Redfin estimated 459% more condo sellers than buyers in San Antonio, 322% more in Houston and 274% more in Miami. Nassau County had an estimated 1,052 sellers and 1,545 buyers, about 32% fewer sellers than buyers, and was the only seller’s market among the 50 most populous metro areas analyzed. That comparison is limited to those markets, not every locality in the country.

Newark and New Brunswick were classified as balanced, along with Chicago, Milwaukee and San Francisco, because the difference between buyers and sellers was within 10%. Newark can have slightly more buyers than sellers without meeting the threshold for a seller’s market. The New York and New Jersey exceptions are a reason not to apply the national surplus directly to a particular neighborhood or building.

The estimates offer a measure of negotiating conditions, not a forecast of future sale prices or a guarantee of affordability. The release does not set out the full buyer-estimation methodology, building-level insurance or association costs, or terms available to an individual buyer. The full report it links was unavailable when checked. Those limits matter when using a national estimate to make a local housing decision: a building’s finances, actual comparable sales and total ownership cost still need separate review.

JBizNews Desk | Seattle, Washington / New York and New Jersey

© JBizNews.com. All rights reserved. Unauthorized reproduction or redistribution is strictly prohibited.

Share this story:
Share by Email
X (Twitter)
Follow Me
Tweet
Whatsapp
LinkedIn
Copy link
Whpq / CC BY-SA 4.0. Toronto skyline from Centre Island, July 31, 2019. Archive geographic illustration, NOT RBC or Yarra premises, acquired assets or a current transaction event. Commons existing five percent vertical crop retained; full supplied native landscape resized with no further crop.

URL has been copied successfully!

Whpq / CC BY-SA 4.0

Royal Bank of Canada announced in Toronto on November 9 that it has agreed to acquire full ownership of Yarra Capital Management, an Australian investment manager with offices in Melbourne and Sydney. Yarra manages about A$18 billion in client assets. That figure describes assets under management, not the purchase price, which the bank did not disclose.

The bank’s announcement said completion is anticipated in the first quarter of 2027, subject to closing conditions including regulatory approval. The agreement is not a completed transfer of ownership, and the release does not identify a specific closing date or say the necessary approvals have already been secured.

Founded in 2017, Yarra has approximately 75 employees and specializes in Australian fixed income, equities and alternative investment solutions. The A$18 billion asset figure is measured as of September 30, 2026. Those are funds managed for investors, not cash that would become RBC’s own balance-sheet assets or the amount paid to Yarra’s owners.

RBC Global Asset Management says the deal would add investment and distribution capabilities as it expands outside North America. Its chief executive, Damon Williams, described Yarra’s Australian fixed-income and equity expertise as complementary to the bank’s existing business. Yarra Executive Chairman Dion Hershan said senior management, including management shareholders, supported joining RBC after a search for a business partner.

For institutional and retail clients, the significance is a proposed ownership change at a domestic investment manager and access to a larger international asset-management network. Yarra also offers international equity products through partnerships with other managers. The announcement does not disclose new client fees, changes to individual fund mandates or a timetable for integrating distribution and operations.

RBC said it does not expect a significant impact on its common equity Tier 1 capital ratio or future ongoing earnings. The capital ratio is a measure of the bank’s regulatory capital strength. That statement is management’s forecast, not evidence that the acquisition has no cost, that every integration expense is known or that future investment returns are assured.

The buyer’s asset-management division says it manages approximately $834 billion across its group of companies and has about 1,600 employees in Canada, the United States, Europe and Asia. The release does not specify the currency of that broader asset figure, so it should not be combined with Yarra’s Australian-dollar total to produce an acquisition valuation or an exchange-rate comparison.

The open questions include the purchase price, financing, detailed approval process, closing date and any eventual operational changes. RBC also warns that approvals may be delayed or unavailable and that Yarra’s business may not perform as expected. Monday’s announcement sets out a proposed expansion in Australian asset management, with execution and the financial terms still to be seen.

JBizNews Desk | Toronto, Canada / Melbourne, Australia

© JBizNews.com. All rights reserved. Unauthorized reproduction or redistribution is strictly prohibited.

Share this story:
Share by Email
X (Twitter)
Follow Me
Tweet
Whatsapp
LinkedIn
Copy link
Bovlb / CC BY-SA 3.0. Carlsbad Village station, California, October 16, 2010. Archive city location illustration, NOT Ionis premises, manufacturing, a launch site or current event. Native 3:2 landscape full image resized, no crop.

URL has been copied successfully!

Bovlb / CC BY-SA 3.0

Ionis Pharmaceuticals, based in Carlsbad, California, lowered its 2026 TRYNGOLZA sales forecast on November 9 to about $50 million from $100 million to $110 million, saying the medicine’s launch in severe hypertriglyceridemia is building more slowly than expected. The company kept its overall 2026 revenue forecast at $875 million to $900 million and left DAWNZERA’s sales outlook unchanged.

The company’s results put TRYNGOLZA’s U.S. net product sales at $9 million in the third quarter and $41 million in the first nine months of 2026. The revised outlook is a forecast for the full year, not a restatement of sales already booked. Management described a more gradual launch ramp as it establishes a new treatment approach and said it had identified opportunities to improve performance, without quantifying their expected effect.

TRYNGOLZA, also called olezarsen, is approved as an addition to diet to reduce triglycerides and acute pancreatitis risk in adults with severe hypertriglyceridemia, according to Ionis. The company also markets it for triglyceride reduction in adults with familial chylomicronemia syndrome. A slower commercial launch is not itself evidence that an approved medicine is ineffective or unsafe; Monday’s sales revision describes adoption and revenue expectations, not a new clinical finding.

DAWNZERA, or donidalorsen, generated $37 million in U.S. net product sales in the quarter and $79 million over nine months. Ionis kept its 2026 product sales guidance at $110 million to $120 million. The medicine is approved to prevent hereditary angioedema attacks in patients age 12 and older. Management said its launch momentum supported the unchanged forecast, but that forecast remains an expectation rather than completed sales.

Total third-quarter revenue rose to $243 million from $157 million a year earlier. Commercial revenue increased to $136 million from $116 million, while research and development revenue rose to $107 million from $41 million. The distinction matters because Ionis’ company-wide revenue includes royalties and collaboration payments as well as sales of its own medicines; it does not measure TRYNGOLZA demand alone.

Ionis remained loss-making. Its third-quarter operating loss under generally accepted accounting principles narrowed to $130 million from $160 million, even as operating expenses rose to $373 million from $317 million. Net loss was $110 million, or 66 cents a share, compared with $129 million, or 80 cents a share, a year earlier. The separate non-GAAP operating loss was $87 million versus $129 million, excluding stock-based compensation. Adjusted figures should not be confused with the reported losses.

Cash, cash equivalents and short-term investments totaled about $1.9 billion at September 30, down from about $2.7 billion at the end of 2025, reflecting debt repayment and cash used in operations, according to the company. Ionis kept its year-end cash outlook above $1.6 billion and its full-year non-GAAP operating-loss forecast at $425 million to $475 million. Those retained targets do not turn the slower product launch into a resolved issue.

The business question is how quickly TRYNGOLZA adoption can improve while other medicines and partnership revenue support the wider company. The release does not give a date for a faster sales ramp or quantify the contribution of individual launch changes. Ionis also said commercial launch of ZANVASTRO for Alexander disease is underway, but it did not provide a standalone full-year sales forecast for that medicine. Management’s results call is scheduled for 9 a.m. Eastern Time on November 9, still ahead at publication.

JBizNews Desk | Carlsbad, California

© JBizNews.com. All rights reserved. Unauthorized reproduction or redistribution is strictly prohibited.

Share this story:
Share by Email
X (Twitter)
Follow Me
Tweet
Whatsapp
LinkedIn
Copy link
CommunistSquared / CC0. Midtown Manhattan skyline, June 27, 2019. Archive New York location illustration, NOT Formation premises, Solana infrastructure or launch event. Full native 3:2 landscape resized without crop.

URL has been copied successfully!

CommunistSquared / CC0

Formation Securities announced in New York on November 9 that it has notified the U.S. Securities and Exchange Commission of plans to operate a tokenized-stock trading venue on Solana, with trading expected to begin in early 2027. The venue is not live, and the notification is not SEC approval or registration of Formation’s planned operation.

The company’s release says tokenized shares of Exodus Movement, Forward Industries and Galaxy Digital, with the respective symbols EXOD, FWDI and GLXY, are anticipated at launch. Superstate and Securitize are expected to make tokenized shares available. These are launch plans, not confirmation that any of the stocks can already be traded on Formation.

Formation intends to use licensed Orca technology for permissioned automated market maker liquidity pools, rather than a conventional order book of standing buy and sell orders. In that model, investors trade against pools of assets using software that determines prices. The company’s notice warns that pool prices may differ from the underlying shares’ prices, particularly when liquidity is low or traditional U.S. stock markets are closed.

“Tokenized stocks will succeed only if public companies see the value in them, and we intend to build this market together with issuers,” said Christopher Montagano, president of Formation Securities. “Formation Securities is designed to give issuers and investors a new, transparent market, with trading beyond traditional market hours and faster settlement onchain, while preserving the key rights shareholders enjoy in the traditional financial space.”

The planned venue would let verified participants hold tokenized shares in wallets they or their custodians control, rather than giving Formation custody of assets or private keys. Trades are intended to settle atomically on Solana: both sides’ assets transfer in the same blockchain transaction, or the asset transfers do not occur. Network fees may still be incurred on a failed transaction. Faster settlement does not remove wallet, software, liquidity or counterparty risks.

Trading is planned around the clock, but not without interruptions. Formation’s public notice says it would stop trading for applicable halts or suspensions in the underlying stock and when required by volume limits. Identity, sanctions and wallet checks would apply, and a wallet must receive venue approval as well as any required tokenizer approval. A public blockchain does not mean anyone can trade these shares without permission.

The regulatory distinction is important. Formation says neither it nor the venue is registered with the SEC in any capacity for the activities performed under the tokenized-securities-venue exemption, and the SEC has not passed on the merits or accuracy of its disclosures. The SEC’s September 17 conditional exemption provides a framework for qualifying venues, not an individual endorsement of Formation. Its notice also says the venue would not be subject to Regulation NMS or the same fair-access requirements as registered exchanges and certain alternative trading systems.

Eligible tokenized stocks must preserve the rights of equivalent traditional shares, including voting and dividends. Formation says it would review backing, corporate-action and rights arrangements before admission, and stop making a token available if equivalent rights no longer apply. The release says issuers’ transfer agents would continue to maintain the official shareholder record. Those protections depend on the tokenization and intermediary arrangements working as described.

Expected access channels named in the release include Alpaca, Passage by CoinList, Anchorage Digital Bank, BitGo Bank & Trust, Fireblocks, Jito’s JTX, Solflare and Squads, alongside Formation’s own platform. Predicate, Sec3, Solidus Labs and TRM Labs are named as planned service providers. These expected integrations should not be read as live distribution or a guarantee that every planned channel will be available in every jurisdiction.

For issuers and investors, the proposal tests another way to trade stock with longer hours and blockchain settlement while keeping shareholder rights. The open questions include the exact opening date, final trading pairs, fee schedule, available liquidity and whether each planned integration and eligibility condition will be ready. Formation says contract addresses and paired assets will be identified before production trading. No trading volume, price reaction or realized investor benefit has been established by Monday’s announcement.

JBizNews Desk | New York

© JBizNews.com. All rights reserved. Unauthorized reproduction or redistribution is strictly prohibited.

Share this story:
Share by Email
X (Twitter)
Follow Me
Tweet
Whatsapp
LinkedIn
Copy link
David Wilson / CC BY 2.0. Lake Charles, Louisiana lakefront, February 24, 2019. Archive city illustration, NOT CKX property, an investment site or current skyline. Includes buildings as photographed in 2019. Full native landscape, no crop.

URL has been copied successfully!

David Wilson / CC BY 2.0

CKX Lands, based in Lake Charles, Louisiana, announced November 9 that Brad Jacobs’ investment firm and co-investors have agreed to put $1 billion in cash into the company, creating a new public-company platform in an industry that has not yet been chosen. Jacobs would become chairman and chief executive at closing while keeping both roles at QXO. The transaction is expected in early 2027 and is not complete.

The joint announcement said Jacobs Private Equity II is expected to provide $900 million, with another $100 million from co-investors led by HRTG Partners, formerly Sequoia Heritage. CKX would be renamed and operate as a standalone company. The release does not identify an acquisition target or say the new venture will be a property developer.

That distinction matters because CKX’s existing business is land management, not the business plan for the proposed new platform. The company’s website says it earns oil and gas royalties, surface rents and timber income from land and mineral interests. Others conduct the exploration, production, farming and timber activities. Monday’s proposal uses CKX as the base for a separate venture whose eventual industry remains open.

Before closing, CKX would convert from a Louisiana corporation to a Delaware corporation and carry out a holding-company reorganization. Each existing common share would become an equivalent share of the new parent before a proposed 4.174438-to-1 reverse stock split. A reverse split combines existing shares into fewer shares; it is not itself new operating revenue or a completed business acquisition.

The investors would receive voting, convertible perpetual preferred stock convertible into about 219 million common shares at a post-split price of $4.57 a share. They would also receive warrants to buy approximately 219 million additional shares. Half the warrants would have a post-split exercise price of $4.57, a quarter $6.85 and the remaining quarter $13.70. Those are transaction terms, not a quote for CKX’s market price or a forecast of investment returns.

Following closing, Jacobs’ firm and its co-investors would own approximately 99.78% of common stock on a fully convertible or exchangeable basis, before any warrant exercise. For existing shareholders, that means the cash distribution and participation in the future venture come alongside a very large change in ownership and control. Conversion and warrant exercise could affect the number of common shares outstanding; the release does not describe them as already issued common shares.

CKX also plans an aggregate $20.8 million cash dividend, stated in the agreement announcement as $10.1312 per share, funded from investment proceeds and cash on hand. The record date is to fall shortly before closing and has not been announced. The dividend is part of the planned transaction, not a payment already made or one that investors can assume applies to any purchase made today.

CKX’s board unanimously approved the transactions, but shareholder approval and other closing conditions remain outstanding. Holders representing about 28% of existing voting power have signed agreements to support the proposal. Those commitments are not the same as a completed shareholder vote. The company said it will prepare a proxy statement with further information for stockholders.

The immediate business significance is a proposed large capital injection and new controlling leadership, rather than an announced operating expansion in Louisiana. The industry, first acquisition, future financing needs, final closing date and dividend record date remain unanswered. Jacobs’ past business record does not settle those questions. A conference call covering the new venture and QXO’s preliminary results and outlook is scheduled for 8:30 a.m. Eastern Time on November 9, still ahead at publication.

JBizNews Desk | Lake Charles, Louisiana

© JBizNews.com. All rights reserved. Unauthorized reproduction or redistribution is strictly prohibited.

Share this story:
Share by Email
X (Twitter)
Follow Me
Tweet
Whatsapp
LinkedIn
Copy link
Northwalker / CC0. Culver City City Hall, archive uploaded February 10, 2019, capture date not specified. Location illustration, NOT ImmunityBio premises, a trial site, treatment or current event. Full native landscape resized without crop.

URL has been copied successfully!

Northwalker / CC0

ImmunityBio said in Culver City, California, on November 9 that ANKTIVA combined with BCG met the primary efficacy endpoint in Cohort A of its randomized QUILT-2.005 bladder cancer trial. The company reported a statistically significant improvement over BCG alone in patients with carcinoma in situ, with or without papillary tumors, but did not release the numerical results needed to judge the size of that benefit.

The company’s announcement concerns high-grade non-muscle-invasive bladder cancer in patients described as BCG-naive, an earlier treatment setting than the BCG-unresponsive population for which ANKTIVA is already approved. Non-muscle-invasive means the cancer has not invaded the bladder’s muscle layer. ANKTIVA and BCG are given directly into the bladder, rather than as systemic chemotherapy.

The study compares the combination with BCG alone and is open-label, meaning the treatment assignment is not concealed. The trial registry identifies Cohort A’s primary outcome as complete response rate at six months and lists a separate disease-free-survival outcome for Cohort B. Monday’s reported primary-endpoint success is for Cohort A, not a claim that every outcome in both groups has been met.

ImmunityBio said enrollment was completed in February 2026 with 370 randomized patients and that the trial involved more than 75 sites. It did not give a separate Cohort A patient count in the release. The registry currently lists 369 actual participants, a small enrollment discrepancy the announcement does not explain. Database lock, the point at which the analysis data were finalized, occurred October 20, according to the company.

The significance is the possibility of adding ANKTIVA earlier in treatment, when patients are receiving BCG-based therapy rather than after their disease has failed to respond to it. A randomized comparison with BCG alone is intended to test whether the additional drug improves outcomes beyond that existing treatment. However, the release does not establish how many more patients responded, how durable any advantage is or whether bladder removal or survival outcomes improved.

ImmunityBio said median duration of response had not yet been reached with the combination and that patient-reported quality of life was maintained. A median that has not been reached is not a promise of permanent response. Without the follow-up duration and the underlying response data, readers cannot determine from the announcement how long the typical benefit will last.

The company reported no treatment-related deaths and said the most common treatment-emergent and treatment-related adverse events were consistent with those seen with BCG alone. It did not provide serious-adverse-event counts or detailed comparative safety tables. Those statements do not mean treatment has no risks, or that uncommon and later side effects have been ruled out.

A supplemental Biologics License Application remains planned for submission to the U.S. Food and Drug Administration by the end of 2026. That is a filing target, not a completed submission or an approval for BCG-naive disease. The company said further study details would be presented at an upcoming medical congress but did not identify the meeting or a presentation date.

The missing information includes response rates, the absolute or relative treatment effect, the p-value, confidence intervals, length of follow-up and detailed serious side effects. Those figures will be needed to assess the strength and practical importance of the result. For now, Monday’s news is a company-reported trial milestone and a planned regulatory filing, not a cure or proof that clinical practice should change.

JBizNews Desk | Culver City, California

© JBizNews.com. All rights reserved. Unauthorized reproduction or redistribution is strictly prohibited.

Share this story:
Share by Email
X (Twitter)
Follow Me
Tweet
Whatsapp
LinkedIn
Copy link

URL has been copied successfully!

The first snow of the 2026 winter season fell on Mount Hermon in Israel overnight between Sunday and Monday. 

Mount Hermon is part of a mountain range bridging the Israel-Lebanon border, with the highest Israeli-controlled peak (Mitzpe Shlagim) reaching 2,224 to 2,236 meters. It also hosts Israel’s only ski resort.

The snowfall followed a weekend of heavy rain and storms that caused severe flooding in several areas of the country.

Footage shared on social media from the Hermon Stream (Banias) Nature Reserve in northern Israel on Sunday shows a rushing Banias waterfall and fast-flowing water in the nearby streams. 

The Kinneret’s water level rose by just one centimeter over the weekend after record rainfall hit central and northern Israel, reaching 213.70 meters below sea level, the Water Authority announced, with the lake still 39 centimeters lower than at the same time last year.

People walk through a flooded street following heavy rainfall in the southern Israeli city of Ashdod, November 7, 2026. (credit: FLASH90)

Water Authority spokesperson Itay Dudi said about 20 millimeters of rain fell over the lake over the weekend, while the Jordan River flow stood at six cubic meters per second.

“The effect of the rain on the river is still small to negligible,” Dudi said, adding that most of the rainfall from the current weather system fell over Israel’s coastal plain, particularly in the south.

Dudi added that, “Over the past decade, there were three winters with worse figures: Exactly one decade ago, the water level was 3 cm higher than it is today.”

According to additional figures released by the Water Authority, the lake’s current level is among the lowest recorded for November 8 over the past decade. In 2017, the water level was 58 centimeters lower than today, while in 2018, it was 94 centimeters lower.

Severe flooding hits Sharon region

In the Sharon region, weekend flooding hit several areas in Kadima-Zoran, prompting the local council to urge residents to stay home and avoid non-essential outings.

According to Israel Meteorological Service data, the Kadima weather station recorded a record 117 mm of rain in just an hour and a quarter, an extraordinary volume for the Sharon region. After the flooding, council teams were dispatched to clear hazards, remove blockages, and drain standing water.

Jerusalem Post Staff, Yanir Yagna, Eli Ashkenazi, Yoav Etiel, and Hodaya Ran contributed to this report.

Share this story:
Share by Email
X (Twitter)
Follow Me
Tweet
Whatsapp
LinkedIn
Copy link

This post was originally published on here. 

URL has been copied successfully!

Prof. Yitshak Kreiss, director of Sheba Medical Center, will temporarily assume the position of Health Ministry director-general in December at the request of Health Minister Haim Katz.

Katz’s request followed the announcement that Health Ministry Director-General Moshe Bar Siman Tov would step down after serving in the role for about nine years across two terms.

“At a time when the State of Israel is facing numerous challenges on multiple fronts, the healthcare system needs a foundation of stability, professionalism, and confidence for Israeli citizens,” Katz said on the temporary appointment. “Ensuring operational continuity and stable leadership at the Health Ministry, one of the country’s most essential government ministries, is therefore particularly important.”

Kreiss, a retired IDF brigadier-general and former IDF chief medical officer, has worked at Sheba for the past decade. He will continue to serve as director of Sheba Medical Center after taking on the director-general role.

“Under his leadership, Sheba Medical Center has achieved exceptional results and established itself as a leading institution in international medicine. His experience and management abilities make him the right person to ensure the stability and continuity needed at the Health Ministry during this period.”

SHEBA MEDICAL Center's new Roman Abramovich Theranostics and Nuclear Medicine Center. (credit: SHEBA MEDICAL CENTER)

Dr. Ze’ev Feldman, chairman of the State Physicians Organization, added that Kreiss is the right person to provide Israel’s healthcare system with the stability it needs.

“The healthcare system needs stability and operational continuity,” said Feldman. “Prof. Kreiss is the right person to maintain and advance the system, particularly during the period of uncertainty we are facing. On behalf of the State Physicians Organization, I would like to wish him success in his new role.”

Sheba, Health Ministry need full-time directors

Prof. Hagai Levine, chairman of the Israel Association of Public Health Physicians, praised Kreiss’ appointment while raising concerns over his handling of two large roles at once.

“Prof. Kreiss is a highly experienced and accomplished physician and medical administrator who is exceptionally well qualified for the position of Health Ministry director-general,” Levine said. 

“His appointment as acting Health Ministry director-general while simultaneously serving as director of Sheba Medical Center at Tel Hashomer constitutes an unhealthy anomaly. Both the Health Ministry and Sheba Medical Center need a full-time director-general. It is unreasonable for one person to perform both roles simultaneously, even temporarily.”

“We hope the appointment will be extremely brief and that a government will be formed very soon, with a permanent, full-time health minister and Health Ministry director-general.”

Share this story:
Share by Email
X (Twitter)
Follow Me
Tweet
Whatsapp
LinkedIn
Copy link

This post was originally published on here. 

URL has been copied successfully!

IDF Chief of Staff Lt.-Gen. Eyal Zamir decided on Monday to establish specialized infantry battalions within the Golani and Nahal Brigades as part of the military’s effort to expand the ground forces’ order of battle.

The IDF’s Ground Forces Command and the Manpower Directorate are spearheading the effort.

The “Alon” Battalion (11) will join the Golani Brigade, and the “Nofech” Battalion (935) will join the Nahal Brigade, though the military has not yet finalized the details of the two battalions.

According to the military, the two battalions will serve as “detection and strike” units. 

They will specialize in drone operations, robotics, surveillance and imagery systems, advanced weaponry, and precision-guided munitions.

IDF Military Drone Unit train with their drones near the Syrian border, northern Golan Heights, June 26, 2025; illustrative. (credit: MICHAEL GILADI/FLASH90)

IDF establishing new corps for countering low-altitude drones

Last month, Walla learned that IDF Ground Forces Commander Maj.-Gen. Nadav Lotan is working to establish a new corps dedicated to countering low-altitude drone threats, as part of an effort to strengthen Israel’s defenses against the growing threat posed by unmanned aerial vehicles.

The corps will initially be based on five battalions that routinely protect the borders with Jordan and Egypt, as well as the security barrier area in the West Bank.

Under the plan, these battalions will assume an additional mission alongside their existing responsibility for defending Israel’s land borders: protecting against mobile threats operating in the airspace close to the ground.

According to assessments, the corps’ sixth battalion will be the tactical air defense battalion established during the war in response to threats from Gaza and Lebanon that emerged on an unprecedented scale.

To support the new corps’ establishment, the IDF will transfer significant resources from the Ground Forces to supplement the Border Defense Corps’ existing capabilities.

These resources will include additional training personnel to develop a drone school focused on defensive missions.

The IDF’s Ground Forces already operate significant defensive drone capabilities, including intelligence-gathering operations conducted using drones by Unit 9900 of the Military Intelligence Directorate.

Military Intelligence is therefore expected to help develop the emerging combat doctrine, operational methods, and the type and scale of procurement involving drones and associated technologies, as well as training.

Amir Bohbot contributed to this report.

Share this story:
Share by Email
X (Twitter)
Follow Me
Tweet
Whatsapp
LinkedIn
Copy link

This post was originally published on here. 

URL has been copied successfully!

For decades, planes have dropped billions of factory-bred sterile flies to keep the flesh-eating New World screwworm out of North America’s cattle. That controls the pest because sterile males mate with wild females, whose eggs then fail to hatch.

But the strategy works only if the supply of flies never runs short.

When the parasite broke through a barrier of sterile flies in Panama in early 2023, the region lacked the capacity to contain it. Efforts to scale up the fly population still lag more than three years into the outbreak, after the parasite ripped through Mexico and into the United States, according to Reuters interviews with 15 current and former officials and experts in the US, Mexico and Panama.

Short on flies, the administration of US President Donald Trump closed the border with Mexico to cattle imports for more than 15 months starting in May 2025, disrupting a multibillion-dollar trade. As the border began to reopen this year, dozens of cases were confirmed in US cattle.

Mexico and Panama currently produce a total of about 150 million sterile flies a week, according to US and Mexican government data.

A reference collection of botflies sits in a petri dish on a counter at the Knipling-Bushland U.S. Livestock Insects Research Laboratory in Kerrville, Texas, U.S. July 14, 2026. (credit: REUTERS/Kaylee Greenlee)

That’s less than a third of the 500 million per week it took during a 1960s campaign that eradicated the screwworm in the US – and that experts recommend as the benchmark to keep the pest contained to south of Panama. The US has no sterile-fly plant of its own, and one under construction in Texas isn’t expected to start production until spring 2027.

Meanwhile, the parasite has spread across most of Mexico, with about 51,000 confirmed cases. The United States has recorded 120 cases to date.

“We don’t have enough flies,” said Sonja Swiger, an entomologist at Texas A&M University. “They knew that right away.”

Political transitions, international tensions hamper efforts to make more flies

Efforts to make more flies at several stages of the infestation have been hampered by political transitions, funding delays, bureaucratic hurdles and rising US-Mexico tensions, current and former government officials told Reuters.

USDA spokesperson Nancy McNiff said in emailed responses to Reuters that the agency has “acted urgently and pursued every practical avenue to get more sterile flies into the field as quickly as possible.”

Spokespeople for Mexican President Claudia Sheinbaum, Mexico’s agriculture ministry, the Panama-United States Commission for the Eradication and Prevention of Screwworm (COPEG) and Panama’s government did not respond to requests for comment.

Alarm in Panama

Screwworm larvae tear through living tissue and can kill untreated animals. A single fly can lay up to 3,000 eggs.

Releases of billions of factory-made sterile flies eradicated screwworm in the US in 1966 and contained a flare-up in Florida in 2017.

In late February 2023, officials in Panama’s Darien province confronted about 800 cases of screwworm inside the jungle that had long served as North America’s last line of defense.

Maintaining that barrier is the job of COPEG, the US-Panamanian organization that gets most of its funding from the US. In April 2023, it decided to increase sterile-fly production to 100 million a week from 20 million a week, said a Panamanian official involved in the response.

By July 2023, Panama declared the spread of screwworm an emergency, expanding sterile-fly releases, tightening livestock controls and intensifying surveillance.

In December 2023, the administration of former US President Joe Biden announced nearly $110 million in additional funding for screwworm detection and sterile-fly production in Panama and elsewhere.

In November 2024, 19 months into the expansion, Panama’s plant reached 100 million flies a week, according to the Panamanian official.

That month Mexico confirmed its first cases in Chiapas, a southern state bordering Guatemala, and began releases.

By then, the authorities knew that 100 million sterile flies a week was not enough, the Panamanian official told Reuters.

Gaps in Mexico

Elections in the United States and Mexico slowed the response.

In September 2024, as President Andres Manuel Lopez Obrador’s administration prepared to leave office, outgoing officials warned their successors that the screwworm epidemic needed immediate attention, a Mexican official familiar with the response said.

Early planning centered on converting an existing fruit-fly plant in Metapa, Chiapas, rather than building a new plant.

The handover delayed the effort by three to four months, the official said, as the new government sorted out funding and prepared a proposal for President Claudia Sheinbaum.

In May 2025, the Trump administration announced $21 million in funding for the Metapa project. US and Mexican officials said the plant could eventually produce 60 million to 100 million sterile flies a week.

Sterile-fly drops from COPEG shifted to the Texas-Mexico border in February 2026.

Sheinbaum pushed agencies to accelerate Mexico’s plant project, seeking an April launch, according to the Mexican government official. In the end, the facility was inaugurated on June 27 – more than 18 months after the country confirmed its first screwworm case.

By then, the parasite had spread across 27 states, reaching major cattle-producing areas of Coahuila and Durango in northern Mexico, hundreds of miles from the southern border.

A plant in Texas

The first US case was confirmed on June 3. But the US still had no production facility of its own.

USDA had begun discussing a facility in November 2024, and field staff met with Texas cattle industry groups about locations that month and in December, according to a former Biden official.

In June 2025, Agriculture Secretary Brooke Rollins said the USDA was considering Moore Air Force Base in Edinburg, Texas, home to a retired fly plant that had been key to the success of the 1960s campaign.

This March, the Trump administration awarded a $610 million contract to M.A. Mortenson to construct the facility, according to publicly available records of the contract through a US government spending database.

The USDA initially believed the project could take up to five years, spokesperson McNiff said.

Administration officials pressed to move faster. USDA limited bids on construction, arguing that open bidding could delay a time-sensitive project, according to the spending records.

At a September meeting of the Texas A&M Board of Regents, Rollins said Defense Secretary Pete Hegseth had moved the project to the top of the Army Corps’ priority list, cutting the timeline to about 18 months, or fall 2027.

John Bellinger, Rollins’ advisor on screwworm and a member of the board, said he pushed to move even faster. “For only $250 million more, we got it moved to April 1 of next year,” Bellinger told the regents, further shortening the timeline by about six months.

Mortenson spokesperson Cameron Snyder said in an email that the company is committed to working with the USDA and the Army Corps to deliver the plant quickly.

Until the plant opens, the United States remains reliant on sterile flies produced elsewhere, roughly 150 million a week combined from the plants in Panama and Metapa, Mexico.

Although Chiapas remains Mexico’s hardest-hit state, with about 8,200 confirmed infestations, USDA said all sterile flies produced in Panama and Mexico are currently being released in northern Mexico and the US.

The strategy aims to stop the parasite’s northward advance before working back south, leaving much of Mexico and Central America reliant on surveillance and treatment, rather than eradication.

Even where cases have been suppressed, protection depends on sterile flies arriving week after week, Swiger said.

Some experts estimate it could take as long as a decade to push the screwworm infestation back to Panama. That leaves North America’s defense against the pest dependent on a biological supply chain that – more than three years into the outbreak – still produces only a fraction of the needed sterile flies.

Share this story:
Share by Email
X (Twitter)
Follow Me
Tweet
Whatsapp
LinkedIn
Copy link

This post was originally published on here. 

URL has been copied successfully!

Over the past week, a number of reports have indicated that Syria is sending forces to Saudi Arabia. The reports differ on the numbers involved. Reuters, the AFP, and now the Associated Press have all reported that Syria is sending forces to Saudi Arabia.

However, it’s not clear if these forces are to help Saudi Arabia with training and advice, or if they will be deployed to Yemen to fight the Houthis. Other questions remain, such as whether this is part of the Syrians also receiving training from Riyadh.

The latest report in the Associated Press says that “Syria is preparing to send fighters to Saudi Arabia to deploy along its border and potentially help it fight Iranian-backed rebels in neighboring Yemen, three officials with knowledge of the plans told The AP.” This report says that “Syrian military advisers have already deployed to Saudi Arabia,” but that they have not been sent to Yemen

The new report notes that “a Syrian official said that an initial force of about 600 Syrian special forces fighters is expected to be deployed to Saudi Arabia in the coming week…The official said that a Syrian delegation led by Khaled Khattab, commander of the 82nd Division, had recently made a two-week visit to Saudi Arabia.”  There are already several dozen Syrians in Saudi Arabia and these are described as “advisors.”

The Syrian support for Saudi Arabia matters. This is because it increases the chance that Syrians will further integrate themselves into a Saudi-led regional order. This dovetails with the new pact that Saudi Arabia has signed with Pakistan and Turkey.

 US Syria Envoy Tom Barrack meets with Saudi Crown Prince Mohammed bin Salman. (credit: SCREENSHOT/X, SECTION 27A COPYRIGHT ACT)

A net gain with Riyadh as Saudi Arabia becomes a leader

For Riyadh, this is a net gain because it wasn’t so long ago that Riyadh had very cold relations with Turkey. Today, much has changed. Saudi Arabia can take pride in being a leader in the region, among both Arab and Muslim countries. This is a historic role it has played.

The revival of Syria as a state is important to Riyadh. For many years, Syria was controlled by the Assad regime. That regime was close to Iran and backed Hezbollah. It was also very close to Russia. As such, the regime in Damascus operated outside the traditional Arab state system. It’s worth recalling some of the history here.

In the post-colonial Middle East that emerged since the 1940s, there have been several key changes in the region. For instance, Egypt’s 1952 revolution eventually led to the emergence of the Arab nationalist Nasser government. In 1958, Egypt and Syria announced a merger as the United Arab Republic. When Egypt intervened in Yemen, the Yemeni forces it was backing also supported the UAR.

Meanwhile, as the Cold War took shape, the West backed the Baghdad Pact, which formed in 1955. This included Iran, Iraq, Pakistan, Turkey, and the UK.

Turkey was a member of NATO. Pakistan remained close with the West and with China. Iraq left the group after a coup in 1959. What matters here for our purposes is understanding that in the 1950s and 1960s the regimes in Egypt and Syria were backed by the Soviets.

Nasser’s government inspired crises in Lebanon in 1958 and in Jordan between 1956 and 1958. It should be recalled that the US and the UK helped confront these crises, with American forces entering Lebanon and British paratroopers sent to Amman.

The Eisenhower administration also mobilized the US Navy. President Dwight Eisenhower ordered around 5,000 US Marines to land in Beirut in July 1958 to stabilize the pro-Western government.

Fast forward several decades and things began to change. Egypt switched sides from the Soviets to the Americans and signed a peace deal with Israel. The Islamic Revolution toppled the Shah. The Soviet invasion of Afghanistan led to the US, Pakistan, Saudis, and others backing the mujahideen rebels.

Radicalization, political Islam led to groups like Al Qaeda

This also dovetailed with radicalization in the region and the rise of political Islam, and eventually Al Qaeda.

In 1990, Saddam Hussein invaded Kuwait. This led the US to deploy forces in Saudi Arabia, which in turn increased US bases in the Gulf: Kuwait, Qatar, the UAE, Bahrain, and other places.

However, the shifts after the 1991 Gulf War weakened many of the historic Arab states. Iraq was weakened in the war and invaded by the US in 2003.

The Arab Spring took place in Tunisia and then spread to Libya, Egypt, Syria, and other places. Iranian-backed proxies such as the Houthis tried to take over Yemen. ISIS was fueled by the Syrian civil war and Iraqi insurgency.

Only in the last decade have things shifted back toward a re-emergence of Arab states. The Assad regime fell in 2024. Iraq defeated ISIS in 2017 and has now struggled with Iranian-backed militias. Egypt under Abdel Fattah al-Sisi has tried to return to its historic role in the region.

Saudi Arabia’s role in Syria is an example of how Riyadh is reclaiming its role in the region and helping Arab states return to their former role. In terms of the historic role of these states, it is worth recalling that Damascus, Cairo, and Baghdad have been centers of Arab and Islamic culture and rule in the past.

It will take time for Syria to become a successful country again. Its work with Riyadh is one step on that path. 

Share this story:
Share by Email
X (Twitter)
Follow Me
Tweet
Whatsapp
LinkedIn
Copy link

This post was originally published on here. 

URL has been copied successfully!

MK Dr. Ahmad Tibi (Joint List) is threatening to sue Eyal Berkovic and Moria Asraf, hosts of the Channel 13 program “Moria and Berko,” for defamation and is demanding NIS 150,000 in compensation over remarks made on air questioning his medical degree.

In a warning letter sent Sunday by his attorney, Gilad Barnea, ahead of possible legal proceedings, Tibi accused the two hosts of making “offensive, humiliating, and racist” remarks about him. Tibi said he would donate any compensation he receives to scholarships for students in need.

The incident occurred during Saturday’s broadcast, when the hosts were speaking with reporter Suleiman Maswadeh about American politician Dr. Abdul El-Sayed.

When Maswadeh introduced El-Sayed as a doctor, Berkovic interrupted and asked, “They give everyone there the title of doctor. Did you check whether he’s actually a doctor?”

Asraf then said, laughing, “He’s not just another ‘dostri,’ he’s a doctor.”

The offices of Israel’s Channel 13 News. (credit: SHUTTERSTOCK)

Hosts question Tibi’s degree

The conversation quickly shifted to Tibi.

“They also say Ahmad Tibi is a doctor,” Berkovic said.

“Of course,” Asraf replied, laughing.

Berkovic continued, “Oh, they say he is. Let him bring his diploma.”

Maswadeh attempted to correct the hosts, saying, “But he is also a doctor,” before emphasizing, “Tibi is also a doctor. I, okay, you’ve taken this discussion in a completely different direction. Tibi is also a doctor, and he was a doctor.”

Berkovic remained unconvinced, saying, “Everyone’s a doctor.”

He then turned to Asraf and said, “Moria is also a doctor. Doctor, what are you a doctor of?”

Asraf replied with a laugh, “My father would have prayed for me to finish my bachelor’s degree.”

Tibi, a trained physician with a medical degree, considered the exchange a deliberate attack on his reputation.

Through his attorney, he argues the remarks constitute defamation under Israeli law and could humiliate him in public, expose him to ridicule, and damage his professional standing and reputation.

Tibi demands public retraction, apology

In the letter, Tibi demands that Berkovic, Asraf, and the companies responsible for the broadcast issue an explicit and detailed retraction and apology during the next episode of the program. He demands that the apology receive the same prominence and exposure as the original remarks.

He is also demanding that the segment be removed from all online platforms, archives, and social media accounts under their control.

The letter gives the recipients seven days from its receipt to comply with the demands. If they fail to do so, Barnea warns that Tibi will pursue legal action, including filing a claim for monetary compensation under Israel’s Defamation Law, which allows damages to be sought without proof of actual harm.

No lawsuit has been filed at this stage, and the matter remains a formal warning ahead of potential legal proceedings.

Channel 13 News told Walla that, as it had stated in its direct response, “There is no substance to the claims,” adding that “Anyone who watched the broadcast could understand that there is no doubt Tibi is a doctor, including the fact that Moria said so herself.”

Share this story:
Share by Email
X (Twitter)
Follow Me
Tweet
Whatsapp
LinkedIn
Copy link

This post was originally published on here. 

URL has been copied successfully!

Orthodox Jewish women in Budapest held a “Kosher & Chic” Fashion Show on Sunday to challenge stereotypes and to show that dressing modestly and according to the rules of their religion doesn’t mean “having to give up who you are.”

Since the 1989 fall of communism, Jewish community life has revived in the Hungarian capital with new schools and renovated synagogues, cultural festivals and concerts.

The models at the fashion show, held in a modern synagogue that also serves as a cultural center, were not professionals but members of one of Budapest’s growing Orthodox communities.

The organizer of the event, Monika Ungar, said the fashion show challenged stereotypes around Orthodox Jewish women and showed that they can dress “really, really beautifully, even though according to the rules.”

A member of the Orthodox Jewish community presents a creation by Hungarian designer Hajnalka Forizs during the ''Kosher & Chic'' fashion show in Budapest, Hungary, November 8, 2026. (credit: BERNADETT SZABO / REUTERS)

Personal values, religious commitment to modesty

Orthodox Jewish modesty rules, known as “tzniut,” generally require women to cover their collarbones, elbows, and knees. Married women often cover their hair with scarves or wigs.

Outsiders sometimes view these practices as restrictive, but participants say they reflect their personal values and religious commitment.

“Modesty isn’t about looking ugly. Modesty isn’t about dressing a certain way that isn’t you. I think in this show you will see a lot of models bring a lot of different kinds of clothing for different designers, and each model finds herself and finds herself the right clothes that really reflect her personality,” said Tzivia Myers, the wife of a rabbi, as she got her makeup fixed before walking out to the catwalk.

Share this story:
Share by Email
X (Twitter)
Follow Me
Tweet
Whatsapp
LinkedIn
Copy link

This post was originally published on here. 

Jeff Dahl / CC BY-SA 2.0. Generic laboratory mass spectrometer and HPLC equipment, 2008 archive illustration. NOT Biond or Rabin premises, trial equipment, patients or treatment. Full native landscape resized without crop.

URL has been copied successfully!

Jeff Dahl / CC BY-SA 2.0

Biond Biologics of Misgav, Israel, said November 9 that the first patient has been treated in a first-in-human study of BND-67, an experimental antibody for advanced solid tumors. The Phase 1 trial begins the work of measuring safety, dosing and early activity in people, rather than establishing that the treatment controls cancer or is ready for routine use.

The company’s announcement said the first patient was treated at the Davidoff Center’s Institute of Oncology at Rabin Medical Center in Israel, one of several participating sites. The study is a dose-escalation trial, in which researchers assess increasing doses while monitoring safety and how the drug behaves in the body.

BND-67 is designed to prevent shedding of CD28, a receptor involved in activating T cells, which are part of the immune system. Biond says losing this receptor from the surface of T cells can weaken immune responses in cancer. The proposed treatment seeks to preserve that signaling, but the mechanism and favorable animal findings do not prove a clinical benefit in people.

The trial begins with BND-67 alone, then adds an anti-PD-1 medicine for patients whose disease relapsed after earlier benefit from that type of immunotherapy. The company said the first patient completed the 0.3-milligram-per-kilogram monotherapy stage without a dose-limiting toxicity or infusion-related reaction and is now receiving BND-67 with nivolumab every two weeks.

That observation is about one patient at an initial dose, not evidence that the drug is broadly safe or more effective than existing treatment. The release did not report tumor response, survival results or a comparison with a control group. A lack of those specific early reactions also does not rule out other or later side effects.

The study aims to assess safety, tolerability, drug exposure and biological effects, along with preliminary anti-tumor activity. For patients who have relapsed after benefiting from immunotherapy, the potential value is a different way to investigate resistance. Whether preserving CD28 can improve outcomes in that setting is the question being tested, not an answer supplied by the first dosing.

Biond, a private clinical-stage biotechnology company, also has a separate Phase 2 program, BND-22, targeting the ILT2 receptor. That program should not be confused with BND-67’s new Phase 1 trial. The two drugs target different parts of immune regulation, and progress in one does not establish safety or effectiveness for the other.

The next unanswered questions are which doses can be tolerated across more patients, whether the combination produces useful activity, and how long any response lasts. The company did not give a results-reporting date or announce a regulatory approval. Monday’s milestone moves BND-67 from preclinical work into human testing, with the central treatment questions still ahead.

JBizNews Desk | Misgav, Israel

© JBizNews.com. All rights reserved. Unauthorized reproduction or redistribution is strictly prohibited.

Share this story:
Share by Email
X (Twitter)
Follow Me
Tweet
Whatsapp
LinkedIn
Copy link
Rhododendrites / CC BY-SA 4.0. Ravenswood Generating Station, Long Island City, from Roosevelt Island, November 24, 2017. Archive image, NOT current condition, ownership transfer or transaction event. Full native landscape resized without crop.

URL has been copied successfully!

Rhododendrites / CC BY-SA 4.0

LS Power announced in New York on November 9 that it has agreed to buy six natural-gas-fired power generation facilities from NRG Energy, with a combined capacity of 4.9 gigawatts. The portfolio includes Ravenswood in New York and plants in Connecticut, Rhode Island and Texas, expanding LS Power’s planned presence in electricity markets where it sees growing demand.

The company’s announcement describes a definitive agreement, not a completed transfer. Closing is expected in 2027 and remains subject to customary conditions and regulatory approvals. It did not disclose a purchase price or provide a specific closing date.

The facilities are Jack County and Johnson County combined-cycle plants in Texas; Ocean State Power in Rhode Island; Ravenswood in New York; R.W. Miller in Texas; and Wallingford in Connecticut. The listed portfolio includes combined-cycle, simple-cycle and steam-turbine generation. The 4.9-gigawatt figure measures generating capacity, not electricity already produced or sold under the new ownership.

LS Power Chief Executive Paul Segal said already built, permitted and interconnected plants can support grid reliability and described firm, dispatchable generation as part of a mix that also includes renewable power and distributed resources. Those are the buyer’s reasons for the acquisition. The release does not quantify how much additional electricity these existing plants will generate after a sale.

For New York and the other affected markets, the immediate change proposed is ownership of existing generating assets, rather than construction of six new plants. That distinction matters when assessing reliability and supply: a purchase agreement does not by itself add 4.9 gigawatts of newly built capacity to the grid.

LS Power said this transaction, together with a separate pending acquisition of about 4.4 gigawatts from Constellation, would increase its natural-gas fleet from 2.2 gigawatts to 11.5 gigawatts. The larger figure depends on both acquisitions, not just Monday’s NRG agreement. The Constellation transaction is also described as pending, rather than already part of the operating fleet.

Including hydro, solar, wind and battery storage, LS Power said its total generation fleet would grow to more than 19 gigawatts. That is the company’s projected portfolio after the transactions. The announcement does not provide a plant-by-plant investment budget, changes in staffing or new customer contracts tied to this deal.

The business significance is a larger position in existing power infrastructure across several regional markets. But the price, financing terms, detailed approval timetable and future operating plans remain undisclosed in the release. It also makes no promise that the ownership transfer will reduce household electricity bills. Whether the transaction closes and what LS Power does with the plants are the next questions.

JBizNews Desk | New York

© JBizNews.com. All rights reserved. Unauthorized reproduction or redistribution is strictly prohibited.

Share this story:
Share by Email
X (Twitter)
Follow Me
Tweet
Whatsapp
LinkedIn
Copy link
CapturedGlimpsesPhoto / CC BY-SA 4.0. Goodyear headquarters, Akron, Ohio, September 2, 2016. Archive image of company building, NOT current leadership event. Full native landscape resized without crop.

URL has been copied successfully!

CapturedGlimpsesPhoto / CC BY-SA 4.0

Goodyear said in Akron, Ohio, on November 9 that Mark Stewart is stepping down immediately as chief executive officer, president and a board member. Director Roger Wood has been appointed interim CEO while the tire maker searches for a permanent successor, a leadership change that comes as an existing board committee reviews the company’s strategy and operations.

The company’s announcement did not give a specific cause for Stewart’s departure. Board Chair Joe Hinrichs said the board considered this the right time to change leadership and accelerate the company’s progress. That is the board’s explanation; the release does not establish misconduct, a dispute or a particular financial event behind the decision.

Wood has served on Goodyear’s board since 2023 and previously was co-chief executive of automotive supplier Tenneco. He also serves on the boards of PHINIA and Brunswick. In taking the interim operating role, he is stepping down as chair of Goodyear’s human capital and compensation committee.

The board is working with an executive search firm to find a permanent CEO. No successor or appointment date was named. Wood said his immediate priorities include supporting employees and customers, improving execution and advancing the transformation work already under way.

The strategic review is not a new committee created with Monday’s CEO announcement. Goodyear said its special committee was formed earlier this year and is evaluating the company’s business mix, operating footprint, efficiency and investment in products and capabilities. The board and Enterprise Transformation Office are continuing that work.

For employees, suppliers and customers, the distinction matters: a review can shape future decisions, but it is not itself an announced factory closure, asset sale or reduction in jobs. Monday’s release did not identify a new transaction, affected facility or staffing plan, and it did not quantify savings expected from the review.

A separate finance leadership change remains ahead. Goodyear reiterated its October 27 announcement that Jerome Rouquet will become executive vice president and chief financial officer on December 1. Rouquet, currently Visteon’s CFO, is to succeed interim CFO Scott Deakin. That appointment has been announced, but its effective date has not yet arrived.

Goodyear says it employs about 60,000 people and manufactures products at 46 facilities in 19 countries. The scale of that network makes the direction of its operating review important beyond the executive office. However, the company did not announce a change to customer service, production commitments or its factory network in this release.

The unanswered questions are who will take the permanent CEO role, when the search will finish and what specific actions emerge from the review. Goodyear said it does not intend to provide further updates unless its board determines additional disclosure is appropriate or required. The announcement changes leadership now, while leaving the next operating decisions open.

JBizNews Desk | Akron, Ohio

© JBizNews.com. All rights reserved. Unauthorized reproduction or redistribution is strictly prohibited.

Share this story:
Share by Email
X (Twitter)
Follow Me
Tweet
Whatsapp
LinkedIn
Copy link
CommunistSquared / CC0. Midtown Manhattan skyline, June 27, 2019. Geographic archive illustration only, NOT KKR premises, portfolio companies, executives or the results event. Full native landscape resized without crop.

URL has been copied successfully!

CommunistSquared / CC0

KKR reported higher third-quarter profit in New York on November 9, with adjusted net income rising 29% to $1.65 billion as assets under management reached $804 billion. The investment firm’s results also showed weaker insurance operating earnings and lower total revenue under standard accounting rules, making the quarter more mixed than the headline adjusted-profit increase alone suggests.

The earnings release put adjusted net income at $1.645 billion, or $1.78 per adjusted share, compared with $1.274 billion, or $1.41, a year earlier. Under generally accepted accounting principles, net income attributable to common stockholders was $1.121 billion, or $1.19 a diluted share, up from $859.9 million, or 90 cents. The adjusted and GAAP measures use different calculations and should not be treated as interchangeable.

Total GAAP revenue declined to $4.564 billion from $5.526 billion. Revenue from asset management and strategic holdings was slightly higher, while insurance revenue fell. Higher profit therefore did not reflect an increase in consolidated revenue. KKR operates across asset management, insurance and strategic holdings, and the different businesses can move in different directions within the same reporting period.

Fee related earnings rose to $1.316 billion from $1.033 billion, and strategic holdings operating earnings increased to $191.6 million from $57.7 million. These are non-GAAP operating measures used by KKR to describe its businesses. Together with insurance operating earnings, they contributed to total operating earnings of $1.738 billion, compared with $1.395 billion a year earlier.

Insurance operating earnings fell to $230.3 million from $304.7 million. KKR said the quarter included a $26 million charge from Global Atlantic’s annual actuarial-assumption review and related items, whereas the prior-year quarter included a $41 million benefit from that review. Excluding those effects, KKR said insurance operating earnings would have been $257 million and $264 million, respectively. The adjustment narrows the comparison, but does not turn the reported decline into growth.

Assets under management rose 11% from a year earlier to about $804 billion, including roughly $648 billion that pays fees. KKR raised about $25 billion in new capital during the quarter and invested about $20 billion. For an investment manager, the scale of fee-paying assets matters because it supports management-fee income, but assets under management are not cash owned by KKR or revenue available to common shareholders.

Co-chief executives Joseph Bae and Scott Nuttall said KKR expects to return more than $40 billion to clients during 2026, more than 50% above its previous annual record. That is a full-year forecast for client capital returns, not confirmation that all the money has already been distributed. The timing of investment sales and other realizations remains important to whether the expectation is met.

KKR approved another $500 million of share-repurchase capacity on November 6. The additional authorization gives it room to buy shares; it does not mean those new purchases have been executed. Separately, the company declared a quarterly common dividend of 19.5 cents a share, payable December 3 to holders of record at the close of business November 19.

For investors, the next questions are whether fee-related growth continues, how insurance earnings develop after the actuarial-review effects, and whether planned realizations deliver the projected client returns. The pace and price of future buybacks are also unresolved. KKR scheduled its earnings call for 10 a.m. Eastern Time Monday, still ahead of publication. The quarter’s reported results do not settle those future outcomes.

JBizNews Desk | New York

© JBizNews.com. All rights reserved. Unauthorized reproduction or redistribution is strictly prohibited.

Share this story:
Share by Email
X (Twitter)
Follow Me
Tweet
Whatsapp
LinkedIn
Copy link
Louis Kang / CC0. Tokyo cityscape, May 28, 2016. Geographic archive illustration only, NOT Rakuten premises, the joint venture event, satellites or current network equipment. Full native landscape resized without crop.

URL has been copied successfully!

Louis Kang / CC0

Rakuten and AST SpaceMobile announced in Tokyo, Japan, on November 9 that they have agreed to create a joint venture to build a satellite network connecting directly to ordinary smartphones. The proposed Rakuten AST company is expected to receive up to ¥148 billion, about $1 billion, in Japanese government support over roughly three years after establishment, with domestic operations targeted by the end of March 2029.

The joint announcement says the partners reached their agreement on November 6, Japan Standard Time, and plan to establish the company during November. The company overview identifies establishment as planned, so the agreement is not confirmation that the new legal entity or network is already operating.

Rakuten Group would hold 51% of the voting rights and AST SpaceMobile Japan Holdings II, a wholly owned indirect Japanese subsidiary of AST SpaceMobile, would hold 49%. The venture’s stated legal capital is ¥100 million. It would be based in Tokyo’s Setagaya ward, with responsibility for satellite procurement and the operation and management of satellite connectivity.

The companies said Japan’s Ministry of Internal Affairs and Communications selected a proposal from Rakuten’s preparatory company and Rakuten Mobile under the J-LEO low Earth orbit satellite communications project. Support is expected through the Communications and Information Network Association of Japan after Rakuten AST is established. The ¥148 billion is an upper limit on expected support over time, not cash already received or the venture’s initial paid-in capital.

AST SpaceMobile would supply the satellites for a Japanese-operated direct-to-device network using mid-band spectrum. The intended service would connect commercially available smartphones without specialized equipment. The partners describe satellite coverage as a complement to ground-based mobile networks, particularly for places with limited terrestrial service and for maintaining communications during disasters.

That matters for businesses whose work depends on connections beyond normal coverage, including logistics, infrastructure monitoring, construction and agriculture. The partners also aim to create a framework for emergency roaming between mobile operators. Those are intended uses and resilience goals, not proof that a completed Japanese network can already provide uninterrupted service in a disaster.

The end-March 2029 target is separate from Rakuten Mobile’s existing plan to begin commercial-environment testing of its satellite-to-mobile service within 2026 under its earlier AST partnership. Testing in a commercial environment is not the same as a nationwide commercial launch. The new announcement does not disclose how many satellites the joint venture will procure or give a detailed launch schedule.

Rakuten Mobile also plans research and development involving AI edge computing and AI-driven spectrum management to support faster communications and industry-specific services. The release describes work to be advanced, not a completed AI spectrum-management system. Potential use of capacity outside Japan would be subject to regulatory approval.

The remaining questions include when the venture is formally established, how the support is disbursed, the satellite and launch timetable, and the final service terms for operators and phone users. Customer pricing, detailed coverage and real-world network performance are not established by this announcement. For now, the partners have set out an ownership structure, a funding ceiling and a service target, rather than announcing a network already in public use.

JBizNews Desk | Tokyo, Japan

© JBizNews.com. All rights reserved. Unauthorized reproduction or redistribution is strictly prohibited.

Share this story:
Share by Email
X (Twitter)
Follow Me
Tweet
Whatsapp
LinkedIn
Copy link
Ynhockey / CC BY-SA 4.0. Tel Aviv and Ramat Gan skylines from Tel Aviv University, July 29, 2022. Geographic archive illustration only, NOT monday.com premises, product, employees or current event. Full native landscape resized without crop.

URL has been copied successfully!

Ynhockey / CC BY-SA 4.0

monday.com, the workplace-software company based in Tel Aviv, Israel, reported a return to quarterly operating profit on November 9 as revenue rose 19% to $377.5 million. But cash generated from operations fell sharply, and management said the move toward an AI-first business is creating near-term operational headwinds.

The company’s results for the three months ended September 30 showed operating income of $31.2 million under generally accepted accounting principles, compared with a $2.4 million operating loss a year earlier. GAAP diluted earnings per share rose to 80 cents from 25 cents. The improvement shows a stronger accounting profit, but it does not mean cash generation improved alongside it.

Operating cash flow fell to $20.4 million from $95.1 million in the same quarter of 2025. Adjusted free cash flow declined to $63 million from $92.3 million. The company’s reconciliation shows why the adjusted figure is higher than operating cash flow: after capital spending and capitalized software costs, unadjusted free cash flow was $15.8 million, and monday.com added back $47.2 million in restructuring-related cash payments.

Those restructuring payments included $32 million in employee-related costs and $15.2 million for settlements and exits from leased office space. The company excludes them from adjusted free cash flow because it considers them tied to a defined restructuring plan rather than ongoing cash generation. They were nevertheless real cash payments, an important distinction for investors comparing the adjusted figure with cash left after capital spending.

On its non-GAAP basis, monday.com reported operating income of $89.4 million and a 24% operating margin, versus $47.5 million and 15% a year earlier. Adjusted diluted earnings were $2.14 a share, compared with $1.16. These measures exclude costs including stock-based compensation, restructuring charges and a non-cash contribution to the monday.com Foundation. They supplement, rather than replace, the standard accounting figures.

The company said its AI offerings reached $36 million in annual recurring revenue, including AI products and subscription-based credits. AI ARR is an annualized measure of contracted recurring business, including an allocation for AI credits included in broader subscriptions, and assumes expiring contracts renew on existing terms. It is not $36 million of AI revenue earned during the quarter and excludes one-time purchases and overages.

For the fourth quarter, monday.com forecast revenue of $380 million to $382 million, representing about 14% growth from a year earlier, below the third quarter’s 19% growth rate. It expects non-GAAP operating income of $68 million to $70 million. Its full-year revenue forecast is $1.473 billion to $1.475 billion, with adjusted free cash flow of $282 million to $288 million. These are management forecasts, not completed results.

Larger accounts remained a source of expansion. Customers with more than $100,000 in annual recurring revenue increased 33% to 2,127, while the overall net dollar retention rate was 108%. Retention measures changes in recurring revenue from existing customers, including expansion, contraction and departures; it is not the percentage of all customers that stayed. Co-founders and co-chief executives Roy Mann and Eran Zinman said the scale of the AI transition introduces operational headwinds even as they remain confident in the strategy.

For business customers and investors, the next test is whether new AI offerings and larger deployments support durable growth without further pressure on cash generation. The scale and duration of the operational headwinds, future restructuring payments and the conversion of AI subscriptions into reported revenue remain uncertain. Management scheduled an earnings webcast for 8:30 a.m. Eastern Time Monday.

JBizNews Desk | Israel Business

© JBizNews.com. All rights reserved. Unauthorized reproduction or redistribution is strictly prohibited.

Share this story:
Share by Email
X (Twitter)
Follow Me
Tweet
Whatsapp
LinkedIn
Copy link
ceedub13 / CC BY 2.0. Ottawa, Canada, October 2, 2009. Geographic archive illustration only, NOT the Paris G7 meeting, announcement, sanctioned persons or organizations. Full native landscape resized without crop.

URL has been copied successfully!

ceedub13 / CC BY 2.0

Canada announced additional sanctions against 38 entities and 24 individuals on November 9, targeting what it described as Russia’s missile-development, cyber and financial support networks. Foreign Affairs Minister Anita Anand announced the measures at the G7 foreign ministers’ meeting in Paris, France, saying Ottawa aims to weaken Russia’s military capabilities and raise the economic costs of its war against Ukraine.

The government release said the additional listings fall under Canada’s Special Economic Measures (Russia) Regulations. It identified the defense industrial base, actors involved in ballistic-missile technology development and Russia’s cyber activities as targets. The announcement did not provide the names of the newly listed people and organizations.

Canada also said it was targeting financial enablers, including cryptocurrency exchanges, that help sustain Russia’s war economy. That is a description of targeted sanctions against financial actors, not an announcement banning cryptocurrency as a whole. The release did not name the exchanges, identify particular tokens or quantify the transactions it seeks to disrupt.

For businesses, the important distinction is between the political announcement and the specific legal listings that determine which counterparties are covered. The release signals that Canada’s action reaches beyond weapons-related actors into financial networks. Without the new names or transaction-level details in the announcement, however, it does not establish that any particular company’s customer, supplier or payment route is affected.

“Canada is taking action to undermine Putin’s capacity to strike Ukrainian cities with its missiles,” Anand said in the release. She said Canada would continue imposing costs until Russia ends its aggression and respects Ukraine’s sovereignty and territorial integrity. The expected reduction in Russia’s military capacity is Canada’s stated aim, not a demonstrated outcome of the measures announced Monday.

The announcement places the new listings within a sanctions campaign dating to 2014. Global Affairs Canada said the country has imposed sanctions on more than 3,500 individuals and entities and more than 700 vessels linked to violations of Ukraine’s sovereignty and territorial integrity and gross and systematic human-rights violations. Those are cumulative figures, not the size of Monday’s new package.

Canada said Russia continues to rely on sanctions-evasion networks to sustain military operations and described cooperation with allies as part of its response. Announcing the measures at a G7 meeting gives the action an international setting, but the release does not say every G7 member adopted the same new listings or that a joint package took effect.

What remains unknown from the announcement is the identity of the new targets, the precise effective time and the value of assets or transactions the measures could affect. It also does not quantify a reduction in missile production, cyber activity or war financing. Those limits matter when assessing the business impact: Canada has announced a wider target list and its intended purpose, not evidence that the targeted networks have already stopped operating.

JBizNews Desk | Global Business

© JBizNews.com. All rights reserved. Unauthorized reproduction or redistribution is strictly prohibited.

Share this story:
Share by Email
X (Twitter)
Follow Me
Tweet
Whatsapp
LinkedIn
Copy link
Rock & roll is not dead / CC0. Rockville Town Square and Library, May 16, 2024. Geographic archive illustration only, NOT Ceva premises, product, customer or current event. Full native landscape resized without crop.

URL has been copied successfully!

Rock & roll is not dead / CC0

Ceva, the chip-design and software licensing company reporting from Rockville, Maryland, said November 9 that third-quarter revenue rose 2% to $29.1 million as royalties recovered from the previous quarter and AI licensing reached a company record. The business still posted a loss under standard accounting rules, showing that stronger demand has not yet translated into an operating profit.

In its quarterly results, Ceva reported $16.3 million in licensing and related revenue, up 2% from a year earlier, and $12.7 million in royalties, up 3% year over year. Royalties rose 18% from the second quarter. The distinction matters: the larger growth figure measures a sequential recovery, not growth from the same period last year.

Ceva licenses technology that other companies incorporate into chips and devices, rather than reporting these royalties as sales of its own finished consumer products. Its customers shipped 623 million Ceva-powered devices during the quarter, matching the company’s previous quarterly record. That count is customer device volume, not Ceva’s own chip shipments or a measure of revenue per device.

AI accounted for more than 35% of licensing and related revenue, which Ceva called a record for its AI licensing business. That percentage does not describe all company revenue. Ceva signed 10 intellectual-property licensing agreements in the quarter, including six for AI technologies and three agreements with first-time customers.

The company said three of its highest-volume connectivity customers extended agreements for multiple years and added more Ceva technology. One added Wi-Fi 6 and Wi-Fi 7 to existing Bluetooth and digital-signal-processing deployments. These arrangements can expand the base for future royalty income, but the announcement did not quantify the revenue each agreement will produce or say when all resulting devices will reach customers.

Chief Executive Amir Panush and Chief Financial Officer Yaniv Arieli pointed to the rollout of internally developed modems at a major U.S. customer as a multiyear smartphone royalty opportunity. Ceva did not name that customer. Arieli also said a significant connectivity agreement expected in the third quarter was signed early in the fourth quarter, underscoring how the timing of individual deals can shift licensing revenue between reporting periods.

Under generally accepted accounting principles, Ceva’s third-quarter net loss was $2.3 million, or 8 cents a share, compared with a $2.5 million loss, or 10 cents a share, a year earlier. Its operating loss widened to $3.5 million from $2.1 million, while gross margin fell to 85% from 88%. A narrower net loss therefore should not be read as an improvement in every measure of operating performance.

On the company’s adjusted, non-GAAP basis, net income was $3.8 million, or 13 cents a diluted share, compared with $2.7 million, or 11 cents, a year earlier. Those figures exclude items including stock-based compensation, amortization and deal-related costs. They supplement rather than replace the reported GAAP loss. Management expects a stronger fourth quarter, but that remains an outlook rather than a completed result.

For investors, the question is whether the royalty recovery and new AI licenses can produce sustained growth while covering costs. The size and timing of future modem royalties, initial neural-processing-unit royalties and revenue from the newly signed agreements remain uncertain. Monday’s release establishes the quarter’s results and management’s expectations, not a guaranteed return from the next product cycle.

JBizNews Desk | Technology

© JBizNews.com. All rights reserved. Unauthorized reproduction or redistribution is strictly prohibited.

Share this story:
Share by Email
X (Twitter)
Follow Me
Tweet
Whatsapp
LinkedIn
Copy link
Davidi Vardi / CC BY 2.5. Holon city aerial, January 12, 2023. Geographic archive illustration only, NOT Compugen premises, trial site, patients or current event. Full native landscape resized without crop.

URL has been copied successfully!

Davidi Vardi / CC BY 2.5

Compugen of Holon, Israel, said November 9 that it has completed enrollment in a randomized ovarian-cancer study, putting the biotechnology company on course for a planned results announcement by the end of the first quarter of 2027. The enrollment milestone moves an experimental maintenance treatment closer to an important test, but does not establish whether the drug works or is safe enough for approval.

The company’s update said its blinded MAIA-ovarian trial enrolled 62 patients, allocated two to one between COM701 and placebo. It is studying COM701 alone as maintenance treatment for patients with second- and third-line relapsed platinum-sensitive ovarian cancer. Maintenance treatment is intended to sustain disease control after earlier treatment, rather than replace the initial course of therapy.

Compugen said it will assess the overall evidence, including how large and lasting the difference between the treatment groups is and the proportion of patients without disease progression at six months. The company described limited maintenance options in this setting. Until the blinded study reports, the enrollment count cannot show whether COM701 improves those outcomes.

The clinical timetable matters to the company’s finances as well as its research. Compugen reported $117.5 million in cash, cash equivalents, short-term deposits and marketable securities at September 30. It expects those resources to support its operating plans into 2029 without additional cash inflows. That is management’s forecast, not a guarantee that costs, trial schedules or funding needs will stay unchanged.

Third-quarter revenue was $3.8 million, compared with $1.9 million a year earlier. Both periods reflected recognition of portions of an upfront payment and an investigational-new-drug milestone payment under its Gilead licensing agreement. Those amounts are not sales of an approved cancer medicine. Net loss narrowed to $5.8 million, or 6 cents a share, from $7 million, or 7 cents a share.

A separate source of potential future income is rilvegostomig, an AstraZeneca-owned antibody whose TIGIT component comes from Compugen’s COM902. Compugen said high-level results from the Phase 3 ARTEMIDE-Biliary01 trial are anticipated in the second half of 2027. That study compares rilvegostomig plus chemotherapy with chemotherapy alone after surgery in 760 participants with biliary tract cancer at risk of recurrence.

Compugen said its AstraZeneca agreement could bring up to $195 million in additional regulatory and commercial milestones, plus royalties on future sales. These are conditional opportunities, not payments already earned or assured. Its Gilead-licensed GS-0321, formerly COM503, remains in an early Phase 1 dose-escalation trial; the company reported $90 million in gross payments received under that agreement and up to $758 million in additional potential milestones.

The update also described UnigenX, an expansion of Compugen’s AI-powered discovery work into tumor-associated antigens for targeted immune therapies. The company introduced that effort at an October 5 investor event. It is a research platform, not a newly approved treatment or a clinical result announced Monday.

The next unanswered questions are whether COM701 produces a meaningful and lasting benefit over placebo, what its safety findings show, and whether the planned reporting dates hold. Partner-controlled programs create additional uncertainty over development and payment timing. For investors, the new enrollment milestone and cash forecast define the next stretch of work; neither removes the scientific risk.

JBizNews Desk | Israel Business

© JBizNews.com. All rights reserved. Unauthorized reproduction or redistribution is strictly prohibited.

Share this story:
Share by Email
X (Twitter)
Follow Me
Tweet
Whatsapp
LinkedIn
Copy link
Image: JBizNews Desk. In-house generated editorial illustration of a generic chip on a circuit board. NOT an actual Nvidia product, facility, person, investigation or event. Full native landscape resized without crop.

URL has been copied successfully!

Image: JBizNews Desk

NEW YORK – U.S. stock futures were higher ahead of Monday’s market open on November 9, while Nvidia shares were down about 6% in premarket trading following the company’s announcement of an independent investigation into reports that chief executive Jensen Huang was targeted by a foreign intelligence effort. The split left investors facing a stronger broad-market indication alongside a sharp move in a major chip stock.

CME’s December E-mini Dow contract, YMZ6, was around 51,880, up about 1.0%, when checked at about 7:22 a.m. Eastern time. December E-mini S&P 500 futures, ESZ6, were around 7,446, up about 0.6%, and December E-mini Nasdaq-100 futures, NQZ6, were around 27,219, up about 0.5%. The Dow, S&P and Nasdaq-100 quotes are delayed by at least 10 minutes, according to CME, and are not the cash indexes’ opening levels.

Nvidia was around $175.50, down approximately 6%, in Nasdaq’s premarket quote at 7:21 a.m. Eastern time. The page showed a prior regular-session close of $186.64 on November 6. The early price is a time-stamped snapshot, not a prediction of where shares will open or finish Monday.

Nvidia’s board statement, dated November 8, says a committee of independent directors, assisted by outside independent counsel, will oversee the investigation. The board said it has no reason to believe national security or Nvidia secrets were compromised, said Huang supports and will cooperate with the review, and expressed confidence in him and his leadership team. The statement did not announce his departure or a finding of wrongdoing.

Oil was also lower in a separate early snapshot. CME’s December West Texas Intermediate contract was $88.59 a barrel, down 2.47%, when its delayed quote page was checked at about 7:09 a.m. Eastern time. That is not a current gasoline price or evidence that diplomatic efforts have succeeded.

The next scheduled U.S. inflation reading is October’s Consumer Price Index on Tuesday, November 10, at 8:30 a.m. Eastern time, according to the BLS schedule. The report has not yet been released. Its results will provide a new reading of consumer-price changes rather than settle in advance how investors or policymakers will respond.

For households with retirement savings, the difference between index futures and one stock’s premarket decline matters. A diversified fund’s result depends on what it owns and how much of each holding it carries. Neither the futures gains nor Nvidia’s decline establishes the return on an individual 401(k), and the early moves can change before the regular session begins.

Lower crude can ease one input into fuel costs, but the EIA says taxes, refining, distribution and local market conditions also shape retail gasoline prices. The morning oil quote therefore does not establish a saving at a particular filling station or a timetable for one.

What remains unknown is whether the broad futures gains will last through the open, where Nvidia will trade during the regular session, and what the board’s investigation will find. Tuesday’s inflation figures are another unresolved input. This morning’s prices show the starting conditions, not those outcomes.

JBizNews Desk | Wall Street

© JBizNews.com. All rights reserved. Unauthorized reproduction or redistribution is strictly prohibited.

Share this story:
Share by Email
X (Twitter)
Follow Me
Tweet
Whatsapp
LinkedIn
Copy link
YHBEST1 / Public domain. Yangshan Deepwater Port Shanghai China 2007 archive trade illustration NOT current imports, named US shipment or announcement. Full frame resized without crop.

URL has been copied successfully!

YHBEST1 / Public domain

China’s Customs Tariff Commission in Beijing, China, said on November 9 that it would continue suspending a 24% additional tariff on U.S.-origin imports for two months while retaining a separate 10% additional tariff. The measure affects goods entering China from the United States, not the duties U.S. importers pay on goods entering America.

The adjustment takes effect at 1:01 p.m. Beijing time on November 10, equivalent to 12:01 a.m. Eastern Standard Time that Tuesday. The ministry statement describes a continuation of the suspension, rather than a newly imposed 24% charge being collected and then immediately removed.

The distinction matters for U.S. companies selling into China and their Chinese buyers. Extending the pause keeps that particular additional 24% tariff from resuming during the stated period. It does not make the affected trade tariff-free, because the announcement explicitly preserves the additional 10% rate.

The commission tied the move to outcomes and understandings reached at the meeting of the Chinese and U.S. heads of state in Washington. That is China’s stated explanation for the measure. The announcement does not, on its own, establish that all trade disputes have been settled or that either country’s wider tariff system has been dismantled.

The measures being adjusted are those set out in the commission’s Announcement No. 4 of 2025. The November 9 statement does not give a complete product-by-product tariff schedule. The retained 10% additional rate should therefore not be presented as the total duty payable on every U.S. product shipped to China.

For American importers, the immediate limit is equally important: a Chinese decision about taxes on imports into China does not itself change U.S. customs charges. Any claim about lower U.S. duties on Chinese goods would require a separate U.S. measure, which this Chinese announcement does not supply.

The commission also said it was watching U.S. statements about using Section 301 tariffs to replace tariffs under the International Emergency Economic Powers Act that had been ruled invalid. It said China would follow subsequent U.S. moves and could adjust its tariff countermeasures as circumstances warranted. Those are Beijing’s account and policy position, not a new U.S. tariff action announced in this notice.

A two-month extension gives the affected trading relationship a defined period without that additional 24% charge. China’s commission said the continuation was intended to provide businesses with a more stable and predictable policy environment. The notice does not quantify savings, name particular companies that benefit or forecast changes in orders and consumer prices.

What happens after the two-month period remains open. The statement includes no U.S. response, no guarantee of a further extension and no complete assessment of other duties on individual goods. Businesses would still need the applicable customs classification and separate tariff rules to determine the full cost of a shipment.

JBizNews Desk | Beijing, China

© JBizNews.com. All rights reserved. Unauthorized reproduction or redistribution is strictly prohibited.

Share this story:
Share by Email
X (Twitter)
Follow Me
Tweet
Whatsapp
LinkedIn
Copy link
File photo of a Tesla Cybertruck on a mountain road, not the Texas factory.

URL has been copied successfully!

Photo: Stephen Leonardi / Pexels

Elon Musk said on November 9 that Tesla would have to return Cybertruck deposits to “a lot of people” because orders exceed the number it can build before shutting down the production line in about eight months. The new statement adds a warning for customers awaiting the electric pickup as Tesla prepares to redirect manufacturing space at its Austin, Texas, plant toward Cybercab.

In his post on X, Musk said the Cybertruck order rate “far exceeds our production rate” and that Tesla would try to make as many trucks as possible before the shutdown. He denied that Cybertruck was unprofitable, instead arguing that its manufacturing complexity carried an opportunity cost outweighed by the value of producing more Cybercabs. Those are Musk’s statements, not independently verified demand, production or profitability results.

Musk did not provide a count of affected customers, the dollar value of deposits to be returned, a refund timetable or evidence of completed refunds. His approximate eight-month horizon is not an exact shutdown date. For customers, the unresolved issue is which orders Tesla will fulfill before the line closes and how remaining deposits will be handled.

Tesla will add an extra Cybertruck production shift to try to clear outstanding orders before it dismantles the pickup’s Texas line around the middle of next year to make room for the Cybercab, Elon Musk said Saturday.

“The Cybertruck order backlog is currently far more than Tesla can make before dismantling the line for Cybercab expansion around June/July next year,” Musk wrote in a post on X. “We will add an extra shift to try to get all orders done in time.”

Tesla reported 8,295 deliveries in its Other Models category in the third quarter, down from 12,364 in the second quarter; the category is not a standalone Cybertruck total.

Musk said Friday on X that Tesla plans to wind down Cybertruck production at its Texas Gigafactory around mid-2027 to make room for more Cybercab production. He called the truck the “best vehicle Tesla has ever made” and the move the “end of an era.”

The production shift would redirect space at the Austin plant from Tesla’s stainless-steel electric pickup toward the vehicle at the center of its robotaxi ambitions.

The future of Cybertruck manufacturing beyond that factory remains unclear: production could move elsewhere or end. The Texas plant is the only known Tesla facility equipped to manufacture the model’s specialized components.

Cybercab takes more of the factory floor

Musk’s plan puts the factory’s next phase behind Cybercab, the autonomous vehicle he has made central to Tesla’s push into self-driving transport. The timetable is around the middle of 2027, rather than an immediate halt to the truck line.

Cybertruck lead engineer Wes Morrill pointed to a technical link between the two vehicles. “Cybertruck was an incredible technology development platform and lives on through Cybercab,” he said on X.

The pickup launched in 2023 as Tesla’s entry into a truck market long dominated by established manufacturers such as Ford. It has struggled to reach the mass-market audience Musk once envisioned, while facing recalls, quality-control issues and repeated price changes.

The planned Texas wind-down is another step in Musk’s effort to turn Tesla from a vehicle maker into a company built around robotics and self-driving services, with Cybercab intended as the main autonomous model in a wider driverless network.

JBizNews Desk | Austin

© JBizNews.com. All rights reserved. Unauthorized reproduction or redistribution is strictly prohibited.

Share this story:
Share by Email
X (Twitter)
Follow Me
Tweet
Whatsapp
LinkedIn
Copy link
Daniel Case / CC BY-SA 3.0 https://creativecommons.org/licenses/by-sa/3.0 . Wide Milan cityscape June21,2016 archive geographic illustration NOT bank premises or merger event. Full panoramic frame resized without crop.

URL has been copied successfully!

Daniel Case / CC BY-SA 3.0

Crédit Agricole of France has proposed talks with Banco BPM over combining the Italian bank with Crédit Agricole Italia into a banking group that would remain listed in Milan, Italy. The French group announced the proposal from Montrouge on November 9, saying the combination would serve 6.5 million customers through more than 2,300 branches.

This is a proposal submitted for Banco BPM’s board to evaluate, not an agreed or approved merger. The Crédit Agricole release says the specific legal structure would be defined between the parties. It describes the planned group as Italy’s third-largest banking group, a company assessment of the proposed combination rather than a new institution already operating.

The proposal includes an exchange ratio based on a 20% valuation premium for Banco BPM and a €1 billion extraordinary dividend for its current shareholders. The premium needs careful reading: it values Banco BPM at a premium relative to the estimated 2027 price-to-earnings multiple used for Crédit Agricole’s contributed businesses. It is not a stated 20% premium to Banco BPM’s stock-market price.

Crédit Agricole would contribute businesses and increase its ownership from its current 29.6% stake in Banco BPM to approximately 45% of the combined entity. The plan also includes contributions from the French group’s Italian life and non-life insurance businesses. The release did not give a numerical share-exchange ratio or a total transaction value.

Crédit Agricole estimates annual synergies of €800 million before tax and an approximately 24% increase in Banco BPM’s 2027 earnings per share. Those are projections, not reported earnings or savings already achieved. The earnings estimate is based on pre-tax run-rate synergies, meaning the expected annual level once the benefits are in place, rather than evidence that all such benefits would be realized during 2027.

The French group says it wants to preserve the combined bank’s Italian identity and operational autonomy, with a majority-independent board and Banco BPM’s current chief executive continuing as chief executive. Those are proposed governance arrangements, subject to the deal moving forward. No Banco BPM acceptance was included in Crédit Agricole’s announcement.

Completion could occur in the second half of 2027, Crédit Agricole said, but would depend on shareholder and regulatory approvals. These include European Central Bank authorization and approval under Italy’s “golden power” regime. The timing is conditional, not a fixed closing date.

A further condition is shareholder approval allowing Crédit Agricole to avoid a mandatory tender offer through the so-called whitewash procedure. The release says the merger would require at least two-thirds of capital represented at Banco BPM’s extraordinary meeting. The tender-offer exemption also has a separate minority-shareholder voting condition, excluding Crédit Agricole and certain other large holders. The proposal therefore cannot be treated as executable solely on the strength of the French group’s existing stake.

The business rationale is to combine local banking networks with insurance, asset management and other financial services. Crédit Agricole Italia already serves 2.9 million customers through about 1,000 branches, according to the release. The proposed larger group would have more scale to invest and serve customers, but the announcement supplies no detailed integration budget, branch plan or staffing commitments.

The immediate question is whether Banco BPM agrees to enter discussions and whether the parties can settle binding terms. Beyond that come votes, regulatory reviews and the work needed to deliver the projected savings. The €1 billion dividend, ownership percentage and earnings benefits remain elements of Crédit Agricole’s proposal, not completed payments or guaranteed outcomes.

JBizNews Desk | Montrouge, France / Milan, Italy

© JBizNews.com. All rights reserved. Unauthorized reproduction or redistribution is strictly prohibited.

Share this story:
Share by Email
X (Twitter)
Follow Me
Tweet
Whatsapp
LinkedIn
Copy link
Simon Mannweiler / CC BY-SA 4.0 https://creativecommons.org/licenses/by-sa/4.0 . Battery storage at Weiher power station Quierschied Saarland 2016. Archive battery-storage illustration NOT Smareg13 or Smareg12 or Envision/ju:niz equipment or project site. Full frame resized, no crop.

URL has been copied successfully!

Simon Mannweiler / CC BY-SA 4.0

Envision Energy and ju:niz Energy announced plans on November 9 to expand their partnership with a 442-megawatt-hour battery storage project in Vöhringen, Bavaria, Germany. The Smareg 13 project, also called Vöhringen II, would add four-hour storage technology to ju:niz’s German portfolio, with Envision supplying its Gen 8 battery energy storage platform.

The announcement describes a project being developed, not 442 megawatt-hours of new capacity already operating. It provides no commissioning date, construction timetable or contract value. It also does not state the system’s power rating in megawatts, a different measure from the amount of energy it can store.

ju:niz will be responsible for developing, financing and realizing Smareg 13 and will operate the system over the long term. Envision’s role centers on its battery storage technology and project delivery. The release did not identify a financing amount, lenders or the terms of the companies’ agreement.

Smareg 13 will be the partners’ third project, taking the combined scale of their collaboration to nearly 600 megawatt-hours. That total covers the partnership, rather than Smareg 13 alone. Envision executive Henry Peng said the larger project is moving forward before the first two projects have completed delivery, so the combined figure should not be read as capacity already delivered under the partnership.

The planned system is next to the operational Smareg 12 facility. That existing site’s operating status is separate from Smareg 13’s development. The announcement does not establish when the new project’s storage will become available to the grid.

Battery storage can hold energy for later use, making it relevant to balancing electricity supply and demand as renewable generation expands. The partners said Smareg 13 is intended to provide more flexibility and balancing capability in Bavaria. Its eventual contribution will depend on completion and operation, not just the announced storage size.

Envision said its Gen 8 platform combines four-hour storage with grid-forming capabilities, which are intended to support the electricity grid. It also described a low-noise design aimed at acoustically sensitive settings and said noise is one of Smareg 13’s site challenges. The release supplies no measured noise levels or independent performance results for this project.

Vural Oezcan, chief operating officer of ju:niz Energy, described the project as having an advanced development status. That assessment does not specify which permits or construction milestones have been completed. The announcement gives no detailed approval record or firm date for the next stage.

The agreement extends a technology relationship around a larger storage project rather than announcing a finished plant. For the German energy system, the issue to watch is when the planned capacity reaches service and how it performs. For the companies, the undisclosed costs, financing terms and delivery schedule leave the project’s financial impact unclear.

JBizNews Desk | Vöhringen, Bavaria, Germany

© JBizNews.com. All rights reserved. Unauthorized reproduction or redistribution is strictly prohibited.

Share this story:
Share by Email
X (Twitter)
Follow Me
Tweet
Whatsapp
LinkedIn
Copy link
Zvika Monar / CC BY 3.0 https://creativecommons.org/licenses/by/3.0 . Karmiel and area September18,2006 archive geographic illustration NOT Protalix facility, patients or trial. Full frame resized, no crop.

URL has been copied successfully!

Zvika Monar / CC BY 3.0

Protalix BioTherapeutics of Carmiel, Israel, released a new analysis of its early-stage PRX-115 gout-drug study on November 9, reporting that participants with longer-lasting measurable drug levels also maintained lower blood uric acid for longer. The individual-participant analysis supports the company’s work on less frequent infusions, but is not a new Phase 2 result or proof of improved symptoms in people with uncontrolled gout.

The company’s announcement covers three higher-dose groups from its Phase 1 single-dose study: 18, 24 and 36 milligrams, with six participants in each group. These adults had elevated plasma uric acid and received a single infusion, with follow-up lasting 85 days.

Protalix said drug exposure increased with dose and persisted longer at higher doses. Participants whose PRX-115 concentrations remained measurable for longer also kept plasma uric acid below the therapeutic target for longer; declining drug concentrations coincided with a gradual recovery in uric acid levels. The analysis examines how drug levels and the biological response relate over time.

The headline finding that mean plasma uric acid stayed below 6.0 milligrams per deciliter for up to 12 weeks after a 36-milligram infusion was previously reported in 2024. What the company is adding now is individual-participant information about that relationship, not a newly completed trial showing 12-week benefit. A group average also does not mean every participant maintained that response.

Safety remains part of the picture. Protalix said the Phase 1 study’s related adverse events were mostly mild to moderate and transient, but one participant had an anaphylactic reaction that resolved. The company’s account says the reaction occurred six minutes into an infusion after about 5% of the planned dose; antihistamine and steroid premedication was subsequently given to all participants. No other serious adverse events were reported, according to the company.

PRX-115 is a plant-cell-produced, modified uricase enzyme being developed for uncontrolled gout. Gout involves elevated uric acid and can cause recurring inflammatory arthritis and joint damage. The treatment’s proposed value is sustained uric-acid lowering with fewer infusions, rather than simply a larger short-term drop in the laboratory measurement. Whether that approach delivers a useful balance of benefit, convenience and safety still needs testing.

The ongoing Phase 2 RELEASE study is double-blind and placebo-controlled, with five planned treatment groups of 30 patients each. It tests 36 milligrams every four weeks without methotrexate, every four, six or eight weeks with methotrexate, and placebo. The main endpoint is the proportion of patients whose serum uric acid remains below 6.0 milligrams per deciliter for at least 80% of the time during the sixth month.

Protalix expects top-line RELEASE results in the second half of 2027. That is a company forecast, not a completed finding. The new analysis does not establish which repeated-dose schedule will work best, whether the candidate is better than existing treatments, or whether regulators will approve it.

The analysis is scheduled for a poster presentation at the American College of Rheumatology’s meeting in Orlando, Florida, on November 10, from 10:30 a.m. to 12:30 p.m. Eastern time. The November 9 announcement previews that presentation; it does not mean the scheduled poster session has already taken place.

For patients and investors following the program, the distinction is between a small early study’s biological signal and the larger treatment question still ahead. The Phase 2 results will be needed to assess sustained response under repeated dosing and add safety information. The release did not provide those outcomes, and the small single-dose analysis cannot settle them.

JBizNews Desk | Carmiel, Israel

© JBizNews.com. All rights reserved. Unauthorized reproduction or redistribution is strictly prohibited.

Share this story:
Share by Email
X (Twitter)
Follow Me
Tweet
Whatsapp
LinkedIn
Copy link

URL has been copied successfully!

Back in the summer of 2023, I was in New York on behalf of a family office scouting a med spa that it was looking to buy. Three years on, the memory that sticks with me is the supply closet.

Its door was wide open, and anyone on staff could simply walk in and take what they wanted off the shelves. When products weren’t there, they were written on a sticky note—or simply remembered by staff—and orders worth tens of thousands of dollars were made on that basis.

I sat down with the owner and asked her: How much have you sold over the last three months? She said she had no idea: current stock wasn’t written down, and if she wanted to do an audit, staff had to go through paper receipts. Later, in the corner of a supply room, I found a box of expired filler worth $50,000 retail. It had never even been opened.

I come from four generations of doctors: My great-grandfather ran a hospital, my grandfather ran a radiology department, and both my parents are physicians—I am the first in the line not to go to medical school. Instead, I did a master’s in public health at Columbia, and after graduating joined a family office in New York.

In 2023, we started looking at rolling up med spas, buying small practices and building them into something bigger. We’d looked at 50 to 60 health care verticals and decided that aesthetics and wellness was the best bet. It had grown massively, from a couple of thousand practices countrywide to close to 20,000 in less than a decade.

But then I started visiting them.

It is standard practice when investing to ask to look at the books, but in many cases there were none. The more practices I visited, the more I realized that this wasn’t a couple of bad apples—this was the industry at large. It is, for the most part, run by clinicians or first-time entrepreneurs with little business background: they weren’t willfully negligent, they had simply never been given the tools.

In a med spa, inventory is the single largest expense, even bigger than payroll.

A vial of Botox, for example, costs several hundred dollars—and it is small enough to fit into a jacket pocket. It would have been easy for me to walk out of any one of those med spas with three vials—worth $2,000—with very little effort. Given the razor-thin margins of many practices in the U.S., that can be the difference between a profit-making month and a loss.

And then there was the safety aspect. God forbid that a state pharmacy board inspector had dropped in at any point because many of these spas could not have produced documentation.

I still visit clinics where there is no Hylenex (a drug used to dissolve hyaluronic acid when a filler injection goes wrong) on the shelf, a serious issue. If filler is accidentally injected into a blood vessel, a patient can suffer permanent tissue damage: Hylenex is the standard emergency treatment, and needs to be on the shelf. I saw clinics that were using unauthorized numbing creams: one bad reaction and a practice would be finished.

So that day in New York, I went back to the family office and told them I didn’t want to help them buy med spas—I wanted to fix them. Their answer was: good luck. If it works, we’ll invest.

I went back on the road, knocking on doors across New York and persuading med spas to let me take over their purchasing: I visited 40 or 50 outlets and came away with seven yeses. Then we signed our first enterprise client and word started to spread. Today we work with the largest med spa groups in the U.S., serving more than 1,500 locations in all.

All that has taught me a lot, but the best lesson I ever received about building a product was from my mother, a physician. When I first described the company to her, everything ordered automatically, no phone calls, no fuss, she said: “I would never use you.”

She said that her sales reps weren’t a nuisance that could be automated away, they were how she learned what was new, what worked and what to watch for.

So we pivoted: instead of trying to replace human reps, we started streamlining the paperwork around them. The vendors noticed their best-run customers were growing and buying more, and started sending new practices our way.

Three years in, I am convinced that the messy supply closet is a microcosm of a much bigger story: wellness businesses are two decades behind the technological curve and it is the simplest problems that are holding them back. Insurance reform and new drugs will play a seismic role in American health care reform, for sure. But equally important are the simplest issues—procurement, purchasing, admin—that help businesses keep the lights on.

Transforming health care doesn’t always start in the operating room or the lab. Sometimes it starts in the supply closet.

The opinions expressed in Fortune.com commentary pieces are solely the views of their authors and do not necessarily reflect the opinions and beliefs of Fortune.

This story was originally featured on Fortune.com

Share this story:
Share by Email
X (Twitter)
Follow Me
Tweet
Whatsapp
LinkedIn
Copy link

This post was originally published here. 

URL has been copied successfully!
  • In today’s CEO Daily: Zendesk’s CEO on using AI firsthand.
  • The big leadership story: Nvidia probes CEO Jensen Huang’s affair with a suspected spy.
  • The markets: Mostly up globally after a wild week of trading.
  • Plus: All the news and watercooler chat from Fortune.

Good morning. Zendesk CEO Tom Eggemeier says he’s been telling his kids since 2023 that AI will be “bigger than the printing press, the internet, the Industrial Revolution,” and that they’d fall behind without it. Earlier this year, his son Will, a Boston College senior and basketball player who’s majoring in history with a minor in business, called his bluff. Will suggested they work together on a predictive analytics app to help college athletics programs find players in the NCAA transfer portal before richer schools do. “We wanted to create something that might be able to level that playing field a little bit,” Will told me during a recent interview alongside his dad. Tom helped design the interface, and they named it Underdog AI.

At first, everything was easy. “We were vibe coding, and it was exciting because of the cool features that were coming out,” Tom said. But Will knew something was off when the AI made recruitment suggestions that didn’t sound right. Speedy development created technical debt in areas from security to API protocols, and hours of debugging that reinforced that there are no shortcuts to making software seamless and secure. Two college basketball general managers told them the app matched about 70% of what’s already for sale; Will also can’t sell to rival schools while he’s on BC’s roster, so he’s tweaking the project until he graduates.

Will says he loved seeing his father work through problems in real time. He’s hoping to build a career in the sports business and believes knowing how to deploy AI is essential to success. He credits his dad with helping him develop grit, citing “suck it up” as a favorite line.

Tom gained as much or more from the experience, saying it made him “a better leader for our R&D organization, our product, and AI.” The experience changed how Tom thinks about AI, from investing heavily in employees’ AI skills to focusing on how AI agents help people cut expenses, time, complexity, or solve other real-world problems. 

Some lessons he’d share with other CEOs?

Use the technology yourself. Tom used a personal agent to renegotiate his insurance coverage, internet bill, mobile plan, and subscriptions, and says he’s “a little embarrassed to say it saved me $3,150 a year.” Having trained ChatGPT Work to write in his voice, he noticed that it kept ignoring his instructions to avoid contractions, which he thinks are harder for non-native English speakers to understand. “That recurring mistake has led me to think more deeply about how memory and skills affect our products and internal use of AI.”

Also, keep hiring young employees; AI natives bring a fluency that creates an interesting dynamic alongside experienced workers. Understand the anxiety around AI while helping people gain skills. Create projects that put AI to work on real problems. And if your kids want to build something with you, do it.

Contact CEO Daily via Diane Brady at diane.brady@fortune.com

This story was originally featured on Fortune.com

Share this story:
Share by Email
X (Twitter)
Follow Me
Tweet
Whatsapp
LinkedIn
Copy link

This post was originally published here. 

URL has been copied successfully!

Good morning. On Fortune’s radar today:

  • Nvidia’s history of questionable statements about Megaspeed executive’s affair with Jensen Huang.
  • AI companies have $3.2 trillion in off-balance-sheet commitments.
  • Markets: Resilience in the face of controversy.
  • There’s an 80% chance the Fed will raise rates in December.
  • The AI investment boom is about to become bigger than the dotcom bubble.
  • Canva cut 1,200 jobs, and the internet loved it.

This story was originally featured on Fortune.com

Share this story:
Share by Email
X (Twitter)
Follow Me
Tweet
Whatsapp
LinkedIn
Copy link

This post was originally published here. 

URL has been copied successfully!

People spoke, and their voices boomed from coast to coast. They do not like data centers and they expect AI to do more harm than good. The numbers are not even close. Voters faced 41 local ballot measures on data centers across 10 states on Tuesday and sided against the industry in every one of them except a single vote in Harwood, North Dakota. In most of those contests, the margin cleared 70 percent. Roughly three quarters of voters told the NBC News exit poll they oppose a data center in their own community, and more than half said AI and data centers were a major factor in their vote. The polls had been saying this for months. Gallup found seven in ten Americans opposed to an AI data center in their area, and Pew finds that Americans who expect AI to hurt society outnumber those who expect it to help by more than two to one.

So what does this mean for what the industry has been calling an unstoppable technology? My personal read is an AI slowdown, at least for now.

Increased regulation

When the new Congress is seated in January, expect a wave of regulation. Some of it will be needed, some of it will be onerous on the industry for no good reason. Mandatory testing of frontier models against government-set standards is worth defining and achieving. We should also expect stronger whistleblower protections for the people inside these labs who see something dangerous and bring it to the public’s attention.

I predict there will also be an attempt to write today’s Executive Branch review of frontier models into statute. We need transparent incident reporting and independent verification organizations. We may also see federal liability, possibly strict liability, with product liability framing and CFAA additions aimed at AI agents. There will be attempts at export controls widening from chips to the equipment that makes them, plus funded chip geolocation.

The change most apparent to the ordinary citizen will be action on surveillance pricing. Surveillance pricing is the use of AI and individual consumer data like browsing history, purchase habits, or location to set a personalized price for each shopper. The FTC moved in August with a proposed enforcement policy stating that undisclosed personalized pricing likely constitutes an unfair or deceptive practice, and states have begun moving on their own. Expect Congress to try to write that into law. Reining this in would bring real relief to the bank accounts of Americans.

We also need a serious debate on pacing. At least two bills already filed, Ro Khanna’s Human Control Over AI Act and the Sanders and Casar superintelligence bill, would prohibit recursive self-improvement outright. Congress will pass a good chunk of this. For the next two years, Trump and his veto pen remain the wild card.

Are we handing the AI race to China?

This view is too alarmist. The United States still leads in chips, capital markets, talent, and open research. A slower, costlier buildout narrows the lead. It does not surrender it. The 10 to 15 gigawatts that analysts say “may never come online” by 2027 is a pacing problem, and a real one. But the cost of the fix is minuscule next to the cost of leaving it unaddressed.

There are terms that even data center opponents will accept, and they are easy wins: pay your own grid upgrade costs, sign longer contracts, publish water and energy use, and flex load at peak hours. If these centers want approval from a public that will not be fooled, they have to pay their own way. Duke University’s Nicholas Institute estimates the existing grid can absorb roughly 76 gigawatts of new flexible load at a 0.25 percent annual curtailment rate. The capacity exists. It will go to the companies willing to accept these terms.

Texas as a data center test lab

States and local governments weighing data centers need to study Texas. Greg Abbott courted the industry harder than any governor in America, then reversed course in August with a pause on new grid connections once the polling turned. It was not enough. Gina Hinojosa, who campaigned on a data center moratorium and a seat at the table for local communities, unseated a three-term incumbent who had never won the office by less than double digits. The pattern held elsewhere. Sherrod Brown won back a Senate seat in Ohio after casting his opponent as a cheerleader for data centers, and Keisha Lance Bottoms won the Georgia governorship while backing a pause on new construction. The lesson for every other state is that once the public turns, a late conversion does not save you. The open question is whether the industry will accept terms that put the costs it expected to share with the public squarely on its own shoulders.

Who wins the slowdown

Another way to lessen the load is shifting AI to distributed hosting, meaning AI processing moves out of a few massive centralized data centers and is split across a coordinated network of smaller regional facilities, edge devices, and on-premises hardware. Training frontier models still requires giant clusters, but inference can live closer to the user at lower peak load.

“My prediction: a more distributed AI map, with many smaller data centers built where spare power already sits, wired together by fiber like a nervous system,” says Andrej Danis, head of digital infrastructure at AlixPartners. “Fewer superclusters may actually give us a more resilient network, and a better one for physical AI. This summer, our survey had sites of 50 megawatts or less as the players most likely to be left behind. A permitting squeeze on the biggest campuses may flip that.”

“Every fully permitted data center under construction just got more valuable,” Danis says. “But many advanced projects do not have their ducks in a row on power, water, and operating permits. Those deserve a hard second look, because after Tuesday a missing permit can kill or delay a project. Tight real estate will also speed up the chip refresh. If you cannot build new halls, you swap in newer chips faster, and the older ones move to other countries where export rules allow. Part of the US slowdown gets exported.”

The part worth arguing about

The industry spent two years telling the public that AI is an existential risk to humanity, and people believed it. That fear campaign now puts the entire technology at risk in the United States. Sam Altman signed a 2023 statement declaring that mitigating the risk of extinction from AI should be a global priority alongside pandemics and nuclear war. OpenAI’s own researchers wrote that superintelligence “could lead to the disempowerment of humanity or even human extinction.” Dario Amodei told the Axios AI+ DC Summit: “I think there’s a 25% chance that things go really, really badly and a 75% chance that things go really, really well, with not much space in between.” If the pilot told you there was a 25% chance your plane would crash, would you get on it?

These AI companies made this mess. It is their job to clean it up. In my estimation, that looks like more payouts in the form of community benefit agreements, revenue shares, tax commitments, and grid upgrades paid in full by the company doing the building. Money alone will not solve this. Communities need the data and resources to make their own decisions, and they will no longer allow their governments to take a check from big tech and shove a data center down their throats. That was made very clear at the ballot box, and it was already visible in last year’s Virginia, New Jersey, and Georgia results.

What compute, AI, and data storage need now is a social contract. The terms are simple. The company pays the full cost of its grid connection, publishes its water and power use, flexes load when the grid is stressed, and shares revenue with the host community. In return, the community gives it a permit, a timeline, and a fair hearing. Companies that treat energy, siting, water, and community economics as strategy will build, because they will work with a community’s citizens, not only its leadership. Those that don’t will have to find a patch of dirt in the middle of absolutely nowhere, or not build at all.

There will be an AI and data-center slowdown. There is no doubt about that. But I am betting on the resilience of the greatest minds in this country to solve the problem and find a way to keep innovating and leading the world. It’s what we’ve always done. It’s what we must do now.

The opinions expressed in Fortune.com commentary pieces are solely the views of their authors and do not necessarily reflect the opinions and beliefs of Fortune.

This story was originally featured on Fortune.com

Share this story:
Share by Email
X (Twitter)
Follow Me
Tweet
Whatsapp
LinkedIn
Copy link

This post was originally published here. 

URL has been copied successfully!

Good morning. Taking on a CFO role for the first time is no small feat. Doing it at Binance, the world’s largest digital currency exchange, in the aftermath of what has been described as the biggest heist in crypto history, is quite another.

Justin Yek, a former VP of finance at Airwallex, will become Binance’s new CFO, succeeding Kaiser Ng, who has held the position since 2022 and is stepping down to pursue a new venture, the company said Saturday. Binance said the transition had been planned for the past six months and had no connection to its recent security breach.

That’s a significant distinction. On Oct. 29, hackers drained an estimated $6.3 billion from the platform, Fortune’s Jeff John Roberts reported. Binance later said North Korean hackers orchestrated the attack, using social engineering and malicious software to compromise engineers and gain access to systems that enabled unauthorized withdrawals.

The damage was partly contained. Tether and Circle froze about $2.5 billion in stolen stablecoins. Binance says it has replenished 98% of the stolen coins through reserve funds and other sources, and that users won’t bear the losses. Read more here.

But, the incident brings questions that go beyond cybersecurity. How strong are Binance’s internal controls? And how can the exchange convince customers and regulators that their assets are safe?

Those are questions that will inevitably land on the new CFO’s desk.

Yek brings a résumé suited to a growing global fintech. At Airwallex, he progressed from head of strategic finance and corporate development to VP of finance, leading the company’s global finance team. Before that, he spent about nine years in investment banking at Citi and Morgan Stanley, working on more than $30 billion in equity, M&A and debt transactions, according to his LinkedIn profile.

That’s substantial experience in corporate finance and dealmaking. But the CFO title is new to Yek, and he lacks the crypto-exchange experience of Ng, who joined Binance from Kraken. 

Cybersecurity is increasingly a finance issue, not just an IT concern. The financial consequences of a breach, including lost assets, customer remediation, regulatory scrutiny and reputational damage, can ultimately fall on the CFO. For example, Deloitte’s Q3 2026 CFO Signals survey found cybersecurity was the top external concern for finance chiefs, cited by 50%, ahead of the economy and inflation. 

At Binance, Yek’s first test as CFO will be helping restore the trust that money alone can’t replace.

Sheryl Estrada
Sheryl.Estrada@fortune.com

This story was originally featured on Fortune.com

Share this story:
Share by Email
X (Twitter)
Follow Me
Tweet
Whatsapp
LinkedIn
Copy link

This post was originally published here. 

URL has been copied successfully!

For the first time in a long time, Nvidia’s investors may be feeling a little cold about their investment’s performance.

Last week, the famed chipmaker and many of its peers in the wider AI and technology industry suffered an estimated $2.5 trillion rout as investors questioned the hurdles facing the sector. The issue is political: The midterms saw Democrats win the Senate, the House, and many statehouses, prompting the question of whether regulation will become more complex under a divided government.

But adding to Nvidia investors’ concerns is the admission of its CEO, Jensen Huang, that he had an affair with an alleged Chinese spy.

Huang’s net worth, tied to the computer processor and AI company he co-founded, stood at just over $171 billion early last week. It dropped to $150.9 billion by Thursday, and briefly rebounded to $154.9 billion by Friday—the latest data point on Bloomberg’s Billionaires Index.

The trajectory follows the path of Nvidia’s share price, now down 18.6% in the past month.

But even as signs of a small reversal bloomed Friday, the weekend brought another blow. “I was unfaithful to my wife. My actions hurt her and our children. There is no excuse for what I did. I am deeply sorry,” Huang said in a statement shared overnight.

“To my colleagues at NVIDIA … you deserve better from me. Leading NVIDIA is the privilege of my life. My responsibility is to serve you and be worthy of your trust. I have fallen short of that responsibility,” he added, saying he would work to “earn back” the confidence of the board, partners and company shareholders.

The woman he had an affair with has been identified in a series of reports as a suspected Chinese spy. Nvidia’s board of directors confirmed in an accompanying statement overnight that it had launched an independent investigation “in light of recent reporting that founder and CEO Jensen Huang has been the target of a foreign intelligence effort.”

The Chinese government has denied involvement in the alleged spy plot involving Huang, calling the debacle “nothing but smears.”

The board added that while it has no reason to believe sensitive national security or NVIDIA “secrets” were compromised, it will “examine all available information.”

Analysts are digesting the news this morning ahead of markets opening in New York. Equities in Asia rallied this morning, noted Deutsche Bank’s Jim Reid, “although concerns surrounding an internal investigation involving Nvidia CEO Jensen Huang are capping gains.”

“The company is down around -3.5% on platforms that provide weekend prices,” he added.

Trump backing

The importance of Nvidia among the companies at the forefront of AI development cannot be overstated. It is the premier supplier of chips to AI companies and one of the largest investors and guarantors of companies in the AI supply chain—to the tune of hundreds of billions.

Yet President Trump was unruffled when asked about one of the country’s most famous CEOs being potentially implicated in a national security threat.

“I have not spoken to [Huang] about it,” Trump told reporters last night. “I just know he’s a fine person, but you never know what is going on.”

Betting on the prediction market Kalshi had the odds of Huang leaving the company before July 27 at 25%. Professor Jeffrey Sonnenfeld, senior associate dean for leadership studies at the Yale School of Management, put the odds of his resignation at 50-50. Huang owns the largest single stake in Nvidia, and his children are among his employees. If he were to leave, there is no obvious successor.

Nvidia’s board said it has “confidence in Jensen and his leadership team.”

President Trump was also confident Huang would continue to lead the company, saying: “He’s done an amazing job for our country.”

This story was originally featured on Fortune.com

Share this story:
Share by Email
X (Twitter)
Follow Me
Tweet
Whatsapp
LinkedIn
Copy link

This post was originally published here. 

URL has been copied successfully!

The Palestinian Authority temporarily suspended land registration transactions last week for people holding Israeli citizenship or Jerusalem residency, following the purchase of eight homes by Jewish activists near Jericho, a city in Area A, according to an official announcement by the Palestinian Land Authority.

Lt.-Col. (res.) Maurice Hirsch, director of the Initiative for Palestinian Authority Accountability and Reform at the Jerusalem Center for Public Affairs, argued that the PA likely believed the Israeli Jews had acquired the homes with the assistance of Arab Israelis.

Palestinian law treats the sale or lease of land to Israeli Jews as an act of treason, which can carry severe penalties, including life imprisonment with hard labor and potentially the death penalty. In 2019, a Nablus court sentenced a Palestinian man to five years in prison for allegedly attempting to sell land to Israeli Jews. In 2018, a Kalkilya court sentenced two Palestinian men to 15 years of hard labor for their involvement in a network seeking to transfer West Bank land to Israeli Jews.

‘Extending consequences beyond Palestinians living under PA jurisdiction’

“The decision exposes a fundamental contradiction in Palestinian Authority policy. While the PA considers Arab citizens and residents of Israel to be Palestinians, it now treats their Israeli citizenship as grounds for restricting their property transactions,” Hirsch wrote in a publication for the JCPA. “…The PA’s latest restrictions on Arab Israelis property transactions represent another dimension of this policy, extending its consequences beyond Palestinians living under PA jurisdiction to Arab citizens and residents of Israel.”

The PA has long regarded the approximately two million Arab citizens of Israel as Palestinian, regardless of their integration into Israeli society, military service, or self-described identities. The latest suspension, though a temporary restriction that has now been lifted, however, introduces one of the first distinctions based on the Israeli citizenship and residency status of Arabs.

Israeli settlers sit at the courtyard of a home, one of few, which Israeli settlers move into, in the Palestinian city of Jericho, in the West Bank, November 5, 2026. (credit: RONEN ZVULUN/REUTERS)

Despite the Oslo Accords excluding Israeli citizens from the PA’s personal jurisdiction, the authority has attempted to prosecute Arab Israelis in the past for their alleged roles in land transfers to Jews and other alleged crimes.

The location of the eight homes is significant

The location of the eight homes is also significant. Although Jericho is in Area A, under PA civil and security control, the properties in question are located in Area C, which is under full Israeli civil and security control. Under the Oslo Accords, the PA’s territorial jurisdiction does not extend to Area C, while Israeli citizens are also excluded from its personal jurisdiction. This raises questions about the PA’s authority to investigate or prosecute Israeli citizens in connection with the purchases, even if Arab Israelis were involved in facilitating the transactions. 

Share this story:
Share by Email
X (Twitter)
Follow Me
Tweet
Whatsapp
LinkedIn
Copy link

This post was originally published on here. 

URL has been copied successfully!

Gadi Eisenkot’s Yashar party invited Shas and United Torah Judaism (UTJ) on Monday to support a formal request to replace Knesset Speaker Amir Ohana during the opening session of the 26th Knesset.

Incoming MK Roy Folkman, who chairs the Yashar Knesset faction, sent letters to the heads of both haredi (ultra-Orthodox) factions, inviting them to join the effort.

According to the letters, the process of collecting signatures ahead of submitting the formal request is underway, and both parties have been invited to participate.

Ohana has said that if at least 61 MKs formally request an early vote, he will schedule one within a week. That gives him room to delay the vote beyond Tuesday, when the 26th Knesset is sworn in, although he has publicly pledged not to obstruct the majority’s wishes.

Support from the haredi parties could strengthen the push for an immediate vote by demonstrating that the demand extends beyond the parties opposing Netanyahu. However, their signatures would not automatically compel Ohana to hold the vote on Tuesday, and the parties seeking his replacement would still need to agree on a candidate.

This is a developing story.

Share this story:
Share by Email
X (Twitter)
Follow Me
Tweet
Whatsapp
LinkedIn
Copy link

This post was originally published on here.